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Dedication
To all families that lost a child to Sudden Unexpected Death in Infancy
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PART 1: GENERAL INTRODUCTION
9
1. Background and rationale:
Sudden unexpected death in infancy (SUDI) is one of the important causes of death in the first year of 
life 1, 2. Various respiratory viruses have been identified in SUDI cases 3-6.  Moreover, a significant 
number of SUDI cases exhibits pathophysiological signs of bacterial infection and inflammation of 
respiratory origin7-9. In addition, pneumocystis infection was identified in cases of infants dying 
suddenly and unexpectedly 10, 11. This high frequency of infections with respiratory pathogens reflects 
the importance of these pathogenic agents in SUDI. However, the number of respiratory pathogens 
investigated is limited and the contribution of bacterial and fungal respiratory pathogens is still 
uncertain. 
Little is known about the aetiology of infections in SUDI in Africa 3, 12. The lack of standardized 
guidelines regarding specimens to be collected, laboratory analysis to be applied as well as 
interpretive guidelines for post-mortem microbiological examination renders the investigation of 
infectious cause of SUDI most challenging.
2. Study aim and objectives: 
The aim of this dissertation was to determine the incidence of respiratory pathogens in cases of 
Sudden Unexpected Death in Infancy (SUDI) and to compare the findings from different techniques 
used in medico-legal investigation of SUDI cases in Cape Town, South Africa. 
3. Thesis outline: 
This dissertation begins with the description of the research protocol (Part 2). It is followed by a 
detailed review (Part 3) that focuses on three main topics: the burden of respiratory pathogens in cases 
of SUDI, the risk factors associated with the occurrence of respiratory infections in SUDI and 
diagnosis of respiratory infections in SUDI cases. Part 4 include a ready to publish article that 
summarises all the important results. Part 5 covers the general discussion of the present dissertation, 
followed by the final part (Part 6) that summarises the general conclusion and perspectives. A list of 
referenced literature is provided after each part. 
References cited
1. Shapiro-Mendoza CK, Camperlengo L, Ludvigsen R, et al. Classification system for the sudden 
unexpected infant death case registry and its application. Pediatrics. 2014; 134: e210-e9.
2. Moon RY and Fu L. Sudden infant death syndrome: an update. Pediatrics in review/American 
Academy of Pediatrics. 2012; 33: 314-20.
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Abstract
Sudden unexpected death in infancy (SUDI) is the leading cause of post-neonatal mortality. Infections 
of the respiratory system are considered as the main cause of death in SUDI. However, the number of 
respiratory pathogens investigated is still limited, which can lead to an underestimation of the 
contribution of respiratory pathogens in SUDI. This study aims to evaluate the role of respiratory 
pathogens in SUDI and examine the correlation among findings from different techniques used in 
medico-legal investigation of SUDI in Cape Town, South Africa. Consecutive cases of SUDI 
admitted at Salt River Forensic Pathology laboratory from September through November 2015 will be 
investigated. This study will follow the routine investigation of SUDI cases at Salt River Forensic 
Pathology Laboratory, Cape Town, South Africa. Risk factors associated with SUDI will be identified 
using a questionnaire given to the family of the deceased infant. An assessment of pathological signs 
of infection in the lungs using Lodox® Statscan® X-ray will be performed followed by a full body 
post-mortem examination by a forensic pathologist. Sections of the brain, heart, lungs, kidneys, 
spleen, and liver will be collected during autopsy for histopathological examination using 
Haematoxylin and Eosin staining microscopy. Cerebrospinal fluid, pericardial fluid, heart blood and 
percutaneous needle lung biopsies will be collected for the detection of 33 respiratory pathogens using 
a set of eight multiplex real-time polymerase chain reactions. Post-mortem microbiology, autopsy, 
histopathology results and findings from the questionnaire will be analyzed to identify respiratory 
pathogens associated with SUDI and associated pathology and risk factors. 
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1. Introduction
Sudden unexpected death in infancy (SUDI) is defined as the death of infants in the interval between 
seven days and one year of age, that occur suddenly and unexpectedly by clinical history 1. Following 
in depth investigation comprising full autopsy, biological examinations, review of the clinical records 
and examination of the death scene, only 15% of SUDI cases is explained, thus referred as “explained 
SUDI”2, while 85% of SUDI cases remain uncertain, therefore classified as “unexplained SUDI” or 
“Sudden Infant Death Syndrome” (SIDS) 2, 3.
In the developed countries, SIDS is the most frequent cause of death among infant less than one year 
of age 4, 5. In England and Wales, unexplained infant death encounters 8% of all infant death 6. A 
higher SIDS incidence rate of 15% was observed in United States of America (USA) 7. In South 
Africa, although limited data is available, SUDI comprises 25% of all medico-legal autopsy cases 
admitted to forensic mortuaries 8. Among them, about 9% are classified as SIDS 8. The highest SIDS 
incidence of approximately 15 % is observed in Cape Town-Tygerberg area in the Western Cape 8.
Epidemiological studies on SUDI mainly focussed on the assessment of risk factors 9, 10. The major 
risk factors identified include prematurity, low birth weight, low income, intrauterine exposure to 
smoking, prone sleeping, genetic, cardiovascular and infectious diseases 10. A high incidence of SIDS, 
a subclass of SUDI, has been observed in populations who exhibit a high incidence of severe 
infectious disease, in particular those affecting the respiratory system 11. An increasing incidence of 
SUDI is observed during cold periods, and more than 70% of SUDI have been linked to infections, 
predominantly pneumonia 12.  Despite significant success with the rollout of pneumococcal conjugate 
vaccine in the past decade 13-15,  pneumonia continues to be a significant health burden especially in 
developing countries 16. In a multi-centre study on forensic investigation procedures and outcomes of 
SUDI in South Africa, about 26% were attributed to pneumonia regardless of considerable disparity in 
the ancillary investigation performed including bacteriology, virology and histopathology 8. 
Investigation of SUDI requires a collaborative approach; different protocols for investigating SUDI 
are available, although it differs across countries as well as within countries 1, 5. Among many others, 
the most well-known protocol is Kennedy’s report, a protocol developed in 2004 by the Royal 
College of Pathologists for care and investigation of sudden unexpected child death 17. It includes a 
broad range of investigation techniques such as examination of the death scene, review of clinical 
history, a full body autopsy, histology, microbiology (bacteriology, virology), toxicology and 
biochemistry 17. It is noteworthy that toxicology is not mandatory in the Kennedy’s report and it is 
only performed in the cases of suspected parental drug use or intentional intoxication 17. Vitreous 
chemistry is not performed on a routine basis in many forensic laboratories due to low rate of 
metabolic diseases and high cost of tandem mass spectrophotometry 18. Liver and kidney histology is 
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used to assess pathological patterns of metabolic diseases rather than the expensive tandem mass 
spectrophotometry 8, 18. 
Respiratory pathogens have been shown to be the leading infectious cause of SUDI 8, 12, 19. However, 
identifying respiratory pathogens involved in SUDI has encountered difficulties related to the 
selection of ideal sampling site for post-mortem microbiology 20 as well as difficulties associated to 
the cultivability of most of the respiratory pathogens 21. In addition, there is limited data on high-
throughput culture-independent techniques for the identification of respiratory pathogens 22, 23.  In 
South Africa, few respiratory viruses (Cytomegalovirus (CMV), Respiratory syncytial viruses (RSV) 
and human Adenoviruses (AdV)) are included in the routine medico-legal investigation of SUDI 
using polymerase chain reaction (PCR)-based methods 23. Hence the role of respiratory infections in 
SUDI might be underestimated due to the low number of pathogens routinely investigated in South 
Africa.
2. Literature review
The cause of death in SUDI is considered to be multi-factorial, played by three related events: critical 
development stage, vulnerable infants and exogenous triggers, constituting the “fatal triangle 
hypothesis” 24. Epidemiological studies have identified many risk factors for explained and non-
explained SUDI and they are found to be similar in both cases 25. The patterns of SIDS rates vary 
greatly with age 26 and the peak incidence is observed between two to four months of age, which 
correspond to the period when the maternal antibodies decrease and the immunity of the infant is still 
immature 27. Preterm infants exhibit an increased incidence of SUDI of about four times higher than 
term infants 28, which has been suggested to be due to the amplified obstructive apnea during sleep in 
preterm babies 29. In addition, an increased incidence of SIDS was reported in male infants compared 
to females 26. This higher incidence of SIDS in male infants can be linked to X-linked genetic 
mutations 30 and also correlated with the higher colonisation of Staphylococcus aureus in males 31.
A disparity in SIDS incidence is also observed among different races 23, 32, 33. In USA, American-
Indian or Alaska-native exhibits a higher mortality rate due to SUDI than other racial groups in this 
country 32, 33. In South Africa, more than 60% of all SUDI cases are observed in black population 23. 
This is probably due to low socio-economic status 34. 
Poetsch et al. demonstrated a correlation between maternal smoking and SIDS incidence 35. The level 
of nicotine metabolic products in infants exposed to cigarette smoke was shown to be similar to those 
of adult smokers 35. This high level of nicotine increases the risk of infection and developmental 
disturbances in infants 35. Prone sleeping position, especially on contaminated surfaces like sofas, also 
increases the level of bacterial colonisation in the upper respiratory tract 33, 36. Furthermore, a 
combined presence of viral pathogens and heat production by heavy wrapping increases the risk of 
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death in infants 37. Epidemiological campaigns mainly focusing on the supine sleeping position were 
initiated in the early 1990s and yielded a significant decrease in SIDS rate in the past two decades 38
2.1 Respiratory infections and SUDI 
The recent interest in investigating the etiological role of infections, more particularly of respiratory 
origin in SUDI, has increased the existing awareness of its causes 39. Infections have been identified 
as one of the major causes of death in explained SUDI as well as a triggering agent in SIDS 9, 22, 40-42.  
For instance, in a large study of more than 1500 paediatric cases conducted in UK; 60% of SUDI 
cases were due to infections, with pneumonia accounting for 20% 9. In Africa, limited data is 
available 8, 23, 43. In Nigeria, 23% of post-neonatal medico-legal cases are attributed to respiratory 
diseases 43 while in South Africa, about 26% of SUDI cases are linked to pneumonia 8. 
Pathological characteristics of infections and inflammation due to bacterial toxins are frequently 
found in post-mortem examination in SIDS infants 9, 44, 45. Significant histopathological findings are 
even observed in macroscopically normal organs 45. Therefore, histopathological signs of 
inflammation provide an easy interpretation of an infectious cause of death in SUDI 45. However, to 
determine the aetiology of the infection, microbiology examination is required 17. 
Post-mortem microbiology is a compulsory ancillary investigation in SUDI 17. Blood, cerebrospinal 
fluid and lung biopsy were considered as most significant samples for post-mortem microbiology 46. 
Moreover, recent research recommended pericardial fluid and liver as the best post-mortem sampling 
sites since they were found to be the most sterile site up to 5 days post-mortem 21. Enormous variation 
of positive results obtained using the shell vial culture in viral screening technique and the low 
sensitivity of bacterial culture technique is a limiting factor in post-mortem microbiology 23, 47. PCR-
based techniques increase the sensitivity of detection of pathogens in post-mortem tissue samples, 
especially in those pathogens that are not routinely cultured 1, 21. 
The interpretation of post-mortem microbiology findings has been always a subject of controversy 47. 
Process of agonal spread and bacterial translocation are considered as major problems in post-mortem 
microbiology 47, 48. However, microbiological findings from post-mortem samples collected at autopsy 
within 48 hours after death are proven to be constant  46. Difficulty in the interpretation of 
microbiological findings was observed in different groups of specialists involved in the routine 
investigation of SUDI cases, consisting of paediatric pathologists, general histopathologists, 
microbiologists, and paediatricians 40 . In 2009, Goldwater proposed that the interpretation of 
microbiological findings should be done by microbiologists 42 . The mere isolation of potential 
pathogens in normally sterile tissues such as blood and cerebrospinal fluid was considered as a 
possible cause of death 20, 49.  Weber et al. suggested that the mere detection of a pathogen in a 
normally sterile site should be considered as a possible cause of death only if it is supported by 
relevant histopathological findings 1.
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An additional feature in the medico-legal investigation in South Africa, particularly in Cape Town is 
the use of the X-ray imaging machine, the Lodox® Statscan® (Lodox Systems (Pty), Ltd., 
Johannesburg, South Africa) in routine autopsy 50. This imaging system was installed in 2007; and is 
the only digital radiograph machine which provides a non-stretched, single, full body radiographic 
image 50, 51. Although it was initially used for identifying fractures and the presence of foreign 
materials such as bullets, the Lodox® Statscan® was reported to be able to detect signs of pathology on 
soft tissue consistent with autopsy findings 51. Additionally, Douglas et al. observed that in 192 SUDI 
cases investigated using Lodox® Statscan® (Lodox Systems (Pty), Ltd., Johannesburg, South Africa), 
80 cases had lung pathology consistent with respiratory infections 51. No further examination was 
done to identify the aetiology of the infection detected using this imaging technique. 
2.2 Justification
The implication of respiratory infections is undeniable, as a number of respiratory pathogens have 
been linked to SUDI 8, 12, 22, 23, 39, 52. About 80% of SUDI cases caused by infections are linked to 
bacteria 9 A significant number of SUDI cases exhibits pathophysiological signs of toxins produced 
by Staphylococcus aureus; Bordetella pertussis and Clostridium perfringens 11, 53. In addition, a high 
prevalence of pneumocystis infection was found in children dying suddenly and unexpectedly 19. The 
viruses mainly associated with SUDI consist of RSV, CMV, human AdV and Enteroviruses 22.
In Africa, data on the infectious causes of SUDI are scarce 8, 23, 43. Only one study conducted in the 
Western Cape Province, South Africa, assessed the respiratory aetiology of SUDI 23. The later study 
focused only on three respiratory viruses, in 82 SUDI cases studied, and found 34, 4and 2 cases 
positive for CMV, RSV and  human AdV, respectively 23. Although the investigated respiratory 
viruses represent the most frequent viral pathogen encountered in hospitalized infants in Cape Town 
54, 55, it might not be representative of cases where infants die suddenly and unexpectedly before or 
upon reaching health care facilities, and the number of investigated pathogens is still limited and 
warranted further investigation, especially for bacterial and fungal respiratory pathogens.
2.3 Aim and Objectives 
This study aims to evaluate the role of respiratory SUDI and examine the correlation between findings 
from different techniques used in medico-legal investigation of SUDI cases in Cape Town, South 
Africa.
Specific objectives of this study are:
i. to identify risk factors associated with SUDI;
ii. to locate signs of infection in lungs of infants who died suddenly and unexpectedly using the 
Lodox® Statscan®; 
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iii. to assess histopathological patterns of infection in the lungs associated with SUDI;
iv. to detect respiratory pathogens in post-mortem specimens from SUDI cases;
v. to evaluate the correlation between radiological, histopathological, microbiological and 
autopsy findings relevant to this study and their significance in the final diagnosis of SUDI.
3. Methodology
3.1 Study design and setting
This prospective, observational, case-control study will investigate cases of sudden unexpected deaths 
in infants of less than one year of age at Salt River Forensic Pathology Laboratory (Cape Town, South 
Africa) from August 2014 through November 2014. The standard procedure routinely used in the 
forensic investigation of SUDI at this institution will be followed (diagram 1). The standard 
microbiological investigation will be done by the National Health Laboratory Service at Groote 
Schuur Hospital, Cape Town, South Africa. Additional samples relevant to this study including 
percutaneous needle lung biopsies, cerebrospinal fluid, heart blood and pericardial fluid will be 
collected for microbiological analyses. Laboratory investigations for the “additional” microbiological 
analysis will be held at the Division of Medical Microbiology, University of Cape Town, South 
Africa. The laboratory at the Division of Medical Microbiology includes a well-equipped molecular 
biology unit, with the unidirectional principle respected. Safety practices are strictly enforced 
following established operating protocols outlined in a Biosafety Manual by the Institute of Infectious 
Diseases and Molecular Medicine (University of Cape Town, South Africa). 
3.2 Study population
Consecutive cases of non-inflicted SUDI aged from 7 to 366 days admitted at Salt River Forensic 
Pathology Laboratory from August 2014 through November 2014 will be enrolled in this study. Age 
and gender matched SUDI cases where the circumstance of death was accidental will be enrolled as 
controls at a 1:2 ratio. 
3.3 Questionnaire
As part of the routine procedure in the investigation of SUDI referred to Salt River Forensic 
Pathology Laboratory, a questionnaire is used to collect socio-demographic data, details about 
household environment, events before death and circumstances around death (appendix 1). 
3.4 Post-mortem examination and X-ray imaging
First, full body X-ray image will be performed using Lodox® Statscan® digital radiography (Lodox®
Systems (Pty), Ltd., Johannesburg, South Africa), and lung pathological patterns assessed by a 
forensic pathologist. Then a thorough external examination as well as a systematic examination of 
internal organs will be done by a forensic pathologist as previously recommended 17. 
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CSF, cerebrospinal fluid
Diagram 1. Flow chart showing “routine” protocol of SUDI investigation at Salt River Forensic 
Pathology Laboratory, Cape Town, South Africa.
3.5 Specimen collection and preservation
3.5.1 Specimen for microbiological analysis: lung biopsy, cerebrospinal fluid, heart blood and 
pericardial fluid
PrimeStore molecular transport medium (MTM) collection tubes (kept at 0 to - 4°C until use) will be 
used for sample collection and preservation according to the manufacturer’s instructions.
Prior to opening the body, a cerebrospinal fluid (CSF) and lung biopsies will be collected. A CSF 
sample will be collected using lumbar puncture as described by Gorman et al. 56. Lung biopsies will 
be obtained from both lungs using a minimally invasive technique, the percutaneous needle lung 
biopsy 16. Furthermore, a pericardial fluid will be obtained via a puncture to the pericardium sac after 
opening the thorax 21. A heart blood sample will be collected after proper sterilization of the heart 
surface following De Jongh et al. procedures 57.
The collected samples in PrimeStore MTM will be immediately (within two hours) transported to the 
Medical Microbiology Laboratory where they will be kept in the freezer at -80°C prior to analysis.
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3.5.2 Tissue samples for histology analysis: brain, heart, lungs, kidneys, spleen, and liver
Sufficiently large (≤ 20 mm) sections of tissues from the brain, heart, lungs, kidneys, spleen and liver 
will be carefully selected by a forensic pathologist from each body. The collected tissues sections will 
be placed into leak-proof small plastic buckets. A sufficient amount of 10% formal saline, 
approximately twice the volume of the tissues will be added to fix the collected tissues 58.
3.6 Histopathology examination
The collected sections of tissues will be prepared for microscopic analysis 58. Briefly, specimens 
collected from each case will be allowed to be properly fixed and dehydrated in different grades of 
alcohol, xylol and liquid wax and embedded in wax and cut into fine sections 58. The resulting fine 
sections will be stained using Haematoxylin and Eosin and handed to a forensic pathologist for 
microscopic analysis of histopathological patterns.
3.7 Microbiological examination
“Additional” microbial investigation refers to the use FTD® respiratory pathogens 33 assay (Fast-
track Diagnostics, Junglinster, Luxembourg), a real-time PCR-based pathogen detection method. 
“Routine” diagnosis refers to the microbiological investigation of SUDI cases as it is normally 
performed at Salt River Forensic Pathology Laboratory using the Anyplex II RV assay (Seegene, 
South Korea) and bacterial culture.
CSF, cerebrospinal fluid
Diagram 2. Flow chart of the microbiological examination
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3.7.1 “Routine” microbiological diagnosis using: CSF, tracheal or lung swab, and heart blood
From each case of SUDI admitted to Salt River Forensic Pathology Laboratory, a bacteriology and 
virology investigation is routinely performed on CSF, tracheal or lung swab, and peripheral blood 
samples collected during autopsy. Blood and CSF are used to isolate the following meningeal 
pathogens: Neisseria meningitidis, Staphylococcus aureus, Streptococcus pneumoniae, Listeria 
monocytogens, Beta haemolytic streptococcus group B and Haemaohilus influenzae. Tracheal or lung  
swabs is used to screen a set of sixteen viral respiratory pathogens (Influenza (A+ B), Parainfluenza 
viruses (1-4), Rhinovirus (A+B+C), Bocavirus (1-4), Human Enterovirus) using a multiplex real-time 
PCR assay, the Anyplex II RV16 detection kit (Seegene, Seoul, South Korea). CMV testing from 
tracheal or lung swabs is only performed on request using monoplex conventional PCR.
3.7.2 Microbiological diagnosis using the FTD® respiratory pathogens 33 assay: CSF, 
pericardial fluid, heart blood and percutaneous needle lung biopsy
Diagram 3 summarizes the workflow for the “additional” microbiological investigation for the 
detection of respiratory pathogens in samples that will be tested.
qPCR, real-time polymarase chain reaction
Diagram 3. “Additional” microbiological investigation  using FTD® respiratory pahogens 33 assay
3.7.2.1 Total nucleic acid extraction  
Total nucleic acid will be extracted from collected CSF, pericardial fluid, heart blood and 
percutaneous needle lung biopsies using a commercialized assay, the QIA-symphony® DSP 
Virus/Pathogen kit in combination of the Complex200 protocol on an automated QIA-symphony SP 
platform (Qiagen, Hilden, Germany) according to the manufacturer’s recommendation with minor 
modifications. For the lung biopsies, a pre-lysis step will be performed before loading to the QIA-
symphony SP instrument. This preliminary step will consist of adding 330 µl of tissue lysis buffer 
(ATL) and 20 µl of proteinase K to 20 mg of lung tissue and thereafter overnight incubation at 56°C  
59. We will use a protocol (complex off-board lysis protocols) that consists of using a starting volume 
of 400µl of the target sample and eluting the total nucleic in 110µl. A batch of 13 samples will be 
extracted. This will include 12 samples of the study population and one negative extraction control. 
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Before total nucleic acid extraction, 4 µl of an extraction control (Equine arteritis virus) will be added 
to each sample, including the negative extraction control. 
3.7.2.2 Real-time PCR screening for respiratory pathogens detection using the FTD® respiratory 
pahogens 33 assay
Detection of target respiratory pathogens will be performed on a Bio-Rad CFX96 TouchTM real-Time 
PCR amplification instrument (Bio-Rad Laboratories, Hercules, CA, USA) using the FTD® 
respiratory 33 pathogens assay (Fast-track Diagnostics, Junglinster, Luxembourg) together with the 
AgPath-IDTM One-Step RT-PCR Kit (Applied Biosystem®, Ambion, USA) according to the 
manufacturer’s instructions. The FTD® respiratory 33 pathogens (Fast-track Diagnostics, Junglinster, 
Luxembourg) comprises a set of eight multiplex real-time PCR reactions (table 1). Each set of 12 
samples will be performed in two Bio-Rad Hard-Shell 96 microplates (Bio-Rad Laboratories, 
Hercules, CA, USA), alongside with a negative (nucleic acid extraction) and a positive control 
(included in the kit provided by Fast-track Diagnostics). Briefly, for each reaction, 10µl of the 
extracted samples will be added to a PCR mix composed of 1.5µl of primer/probe mix (Fast-track 
Diagnostics, Junglinster, Luxembourg), 1µl of 25x RT-PCR enzyme mix (AgPath-IDTM One-Step RT-
PCR Kit, Applied Biosystem®, Ambion, USA)  and 12.5µl of 2x RT-PCR buffer (AgPath-IDTM One-
Step RT-PCR Kit, Applied Biosystem®, Ambion, USA). Cycling will be as follow: initial heat at 50°C 
for 15 minutes, denaturation at 95°C for 10 minutes and 40 amplification cycles at 95°C for 8 seconds 
and 60°C for 34 seconds according to the maufacturer’s instuctions. Genes target for the detection of
different microorganisms included in the FTD® respiratory 33 pathogens assay are listed in Table 1. 
PCR products within each multiplex will be detected using a dual labelled molecular probe for each 
pathogen of the multiplex. In order to interpret the real-time PCR results, the negative control should 
show no amplification and the positive control an exponential amplification curve. Positive results 
will be indicated by a well defined curve crossing the cycling treshold value according to the 
manufacture’s recommendation. To be considered as valid results, the real-time PCR findings will be 
agreed by two scientists. Then data will be automatically exported into the Miscrosft Excell 
(Microsoftcorp, Redmond, WA, USA) file using FTD Resp33 qPCR Analyser  version 1.0 software 
(http://www.gematics.com/analyser.html accesed on the 26th August 2014) for further analysis. 
3.8 Statistical analysis
Data will be analysed using  Stata version 10.0 software (StataCorp, College Station, TX, USA). We 
will perform a univariate analysis to describe the socio-demographic and the incidence of respiration 
infection in the study population. A multiple logistic regression analysis will be performed to identify 
factors independently associated with SUDI. Mann-Whittney U test will be used to compare 
differences in continous variables between the SUDI cases and controls. Differences in risk factors 
exposure between the cases and controls will be compared using chi-square test or  Fisher’s exact 
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two-tailed statistics, where appropriate. Kappa statistics will be used to assess the agreement between 
the investigation methods. The kappa coeficient will be interpreted as proposed by Landis and Koch 
60: 0.81 - 1.00 = excellent agreement, 0.61 - 0.80 = good agreement, 0.41 - 0.60 = moderate 
agreement, 0.21 - 0.40 = fair agreement, 0 - 0.20 = poor agreement, and <0 = no agreement. For all 
statistical tests, a p-values of less than 0.05 will be considered significant.
4. Limitations of this project
No upper respiratory specimen will be used in this investigation due to the proliferation of indigenous 
microorganisms of the upper airways after death 61. Therefore, the microorganism’s colonisation at 
the time of post-mortem examination does not reflect the ante-mortem situation. In addition, 
intentional poisoning and metabolic diseases in SUDI are not in the scope of this study; hence, neither 
toxicology nor clinical chemistry screening will be examined. 
5. Ethical considerations and data management
This research protocol will be submitted to the University of Cape Town Human Research Ethics 
committee for approval. According to the South African Inquests Act 58 of 1959, a medico-legal 
investigation of all unnatural deaths including SUDI cases is mandatory, hence written consent from 
the deceased family will not be required for this study. Only the inquest case number assigned to each 
SUDI will be revealed to the investigators. All post-mortem examination and ancillary investigation 
data will be kept securely at the Divisions of Forensic Medicine and Medical Microbiology, 
University of Cape Town, South Africa. This research will follow the routine investigation of SUDI 
cases at Salt River Forensic Pathology laboratory, Cape Town, South Africa. The findings of this 
research will not be communicated to the family of the deceased for the reason that the assay that will 
be used is not validated for diagnostic purpose.
6. Expected output, outcomes and impacts
This research is unique, since it will be able to screen thirty three pathogens. The case-control design 
will provide a valuable tool in the identification of possible SUDI aetiology regarding the possible 
disparity in pathogens colonisation in both groups.
In Cape Town particularly, this research has an epidemiological value of identifying respiratory 
pathogens and associated risk factors contributing to the high incidence of sudden unexpected infant 
death and could lead to effective approaches to SUDI prevention and control.
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Table 1. Target pathogens in the FTD respiratory pathogens 33 multiplex real-time PCR 
assay
Multiplex no. Primer/Probe mix Target pathogen Target gene sequences 
1 FluAB-RH Influenza A Matrix gene (post1)
Influenza B Segment 8 NS1/NEP
Rhinovirus 5’untranslated Region (UTR)
2 Para-EAV Parainfluenza 3 Hemagglutinin-neuraminidase (HN) mRNA
Parainfluenza 2 Hemagglutinin-neuraminidase (HN) mRNA
Parainfluenza 4 Fusion protein gene
Internal control*
3 Cor Coronavirus 229 Nucleocapsid protein (N) gene
Coronavirus 63 Nucleocapsid protein (N) gene
Coronavirus HKU1 Nucleocapsid protein (N) gene
Coronavirus 43 Nucleocapsid protein (N) gene
4 BoMpPf1 Parainfluenza 1 Hemagglutinin-neuraminidase (HN) mRNA
Human Metapneumoviruses A Fusion glycoprotein (F) gene
Human Metapneumoviruses B Fusion glycoprotein (F) gene
Bocavirus NP1 gene
Mycoplasma pneumoniae Adhesin P1
5 RsEPAcmv Respiratory syncytial viruses A Nucleocapsid protein gene
Respiratory syncytial viruses B Nucleoprotein mRNA
Cytomegalovirus US7+US8 genes
Enterovirus Parts of domain IV and V
Parechovirus 5’untranslated Region (UTR)
Adenovirus Hexon gene
6 Bac Staphylococcus aureus Sensor histidin kinase vick gene
Chlamydia penumoniae RNA polymerase beta chain gene
Haemophilus influenza B BexA gene
Streptococcus pneumoniae LytA gene
7 KLePSa Pneumocystis jiroveci (mtLSU)r RNA gene
Legionella spp 16 S rRNA
Klebsiella pneumoniae Khe hemolysin gene
Salmonella spp Tetrathionate subunit B (ttrB)
8 MoBoCH Moraxella catarrhalis CopB gene
Influenza C Matrix gene
Bordetella pertussis IS481
Haemophilus influenzae spp ompP2 gene
No., number, *, Equine arteritis virus
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7. Research budget
Table 2. Estimated budget for microbial investigation using the Fast-track diagnostic assay.
Item Description Amount (ZAR)
QIA-symphony® DSP Virus/Pathogen kit Nucleic acids extraction kit 6 000 
FTD respiratory pathogens33 kit  + Fast track 
Master mix
Multiplex Real Time PCR for detection of 
respiratory pathogens
33 033.60 
PrimeStore Molecular transport medium (MTM) Molecular transport medium 6 500 
Equipment and consumables Will be provided by the division of 
Medical Microbiology
-
Total 45 533.6 
8. Research timeline
Table3. Research timeline
Apr, April; Aug, August; Dec, December; Jul, July; Jun, June; Nov, November; Oct, October; Sept, September 
Task Start End Duration Apr May Jun Jul Aug Sept Oct Nov Dec
Planning, Proposal & Ethics Apr Jul 16 weeks
Literature review Jun Aug 12 weeks
Sample collection & analysis Aug Oct 12 weeks
Results & Discussion writing Oct Nov 8weeks
Article writing Nov Dec 8 weeks
Submission of the project 
and article for publishing
Dec Dec 4 weeks
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Supplementary materials
Supplementary material 1. Research questionnaire
FORENSIC PATHOLOGY SERVICE  
SUDI [Complete If A Baby Should Suddenly And Unexpectedly Die] 
FPS laboratory________________________________                     WC _______________________ 
Name of baby ________________________________ 
Section A. 
Who gives the history/ information in this case e.g. mother/father/granny/grandpa/other 
relative(give details)
Name:                                                                                                Relationship: 
Address:                                                                                           Contact telephone number: 
ID Number: 
Infants full name:    
Home Address:        




Person(s) at/called to the scene and relationship
Name/relationship Date Time 
Name/relationship Date Time 
Name/relationship Date Time 
Police response/name Date Time 
Paramedic response/name Date Time 
When was the death certified/by whom Date Time 
If the baby was taken to hospital 
Name of hospital 
Date of arrival:                                                                                      Time of arrival: 
Name of doctor seen / declared death: 
Comment:  Get copies of doctors notes 
Was resuscitation done on the baby by the paramedic or the doctors at the hospital? 
Section C 
Household environment: 
Place where baby lives:                                                           house       shack       other –
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Number of bedrooms  
Is the room in which the baby is found well ventilated? 
Odour(s) present in the room the baby slept in?  Yes No
Peeling paint in the room the baby slept in? Yes No
Fungal growth (mould) in the room the baby slept in? Yes No
Did people smoke cigarettes in the room the baby slept? Yes No
Are there pets in the house?   
If yes – type and number:     
Yes No
Did caregiver use alcohol or drugs on the night baby died? Yes No
Was there a heater or open fire or galley blik or other heating device in room where baby slept? Yes No
In what position was the baby found lying? 
Has the baby been moved? 
Were there any covers/ clothing etc. over the baby’s head? 
Was the baby squashed/wedged between anything (object)? Yes No 
Was there overlaying (someone lay on top of the baby)?    Yes No 
Comments from forensic officer who attended the scene: 
Section D 
Circumstances of death / details about events before death 
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1.  When was the baby last seen alive Date Time 
2.  Who last saw the baby alive 
3.  When was the baby found dead Date Time 
4.  Who found the baby dead at the scene 
5.  Was the baby ill?   Yes No 
a)  If yes – What was wrong and for how long? 
b)  Was the baby taken to the doctor or pharmacy or clinic or traditional healer for the 
illness? 
When (date and time)?   
Yes No 
c)  If not, why not: 
d)  Was the baby admitted to a hospital or clinic for the 
illness: When (date and time)? 
Yes No 
e)  If not, do you know why not? 
f)  What medication was given (names please  
6.  Where was the baby found dead Bed Couch Cot  Floor Other 
Other: 
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7.  Did the baby sustain any injuries – eg by falling or being hit: 
If yes: 
Yes No 
a)  When did it happen? 
b)  How did it happen? 
c)  Where did it happen? 
d)  What did the caretaker do about it? 





















b) If placed on a bed/cot, what was the mattress type Foam 
rubber 
Inner spring Other 
c)  Was the mattress covered with a blanket or sheet Yes No 
d)  What position was the baby placed when put to sleep? Back Stomach Side Other 
Other -
e)  what was used to cover the baby:  List items 
e)  What position was the baby found dead? Back  Stomach Side Other 
Other –
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f)  Has the baby been moved? Yes No 
g)  Face position when the baby was found dead To the left To the right Face down 
Face up Unknown 
h)  Face and or chest squashed / wedged between any object(s) when the 
baby was found dead? 
Yes No  Unknown 
If yes – details please –
i)  Was the nose and mouth of the baby covered by anything – eg 
blankets or anything else 
Yes No  Unknown 
j)  Were there other items in contact with the baby – eg pillow Yes No Unknown 
k) Did the baby use a Dummy (pacifier)? Yes No 
l) Did the baby sleep in the same bed as the mother? Yes No 
m)  Did the baby sleep in her arms? Yes No 
n) Did the baby sleep on her chest? Yes No 
o)  Did the baby sleep with the mother on a couch? Yes No 
p)  How many other people slept on the same bed as the baby at the time the baby died?   
q)  Was anyone found on top of the baby while in the bed (Overlaying)? Yes No 
r)  Was the window where the baby slept on the day /night the baby died Open Closed 
s)  Did the mother or anyone in the house smoke while the baby slept on the night/day 
of death? 
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t)  When was the baby last fed? Date Time 
u)  Did the mother/caregiver use alcohol before going to bed with the baby on the night/day the 
baby was found dead? 
If yes, how much? 
Yes No 
v)  Did the mother/caregiver use drugs before going to bed with the baby on the night/day the 
baby was found dead? 
If yes, what drugs? 
Yes No 
w)  Did the mother/caregiver give the baby medication on the night/day of death?        If 







1.  Where was the baby born? Hospital Clinic Home Other 
Name of hospital/clinic/other 





3.  How much did the baby weigh at birth? 
4.  Was the baby  Premature Full term Postdates
(Overdue) 
5.  If the baby was premature, how premature was it? 
6.  Did the baby receive Kangaroo care (KMC) Yes No 
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7.  Did the mother carry the baby on her back? Yes No 





If formula, name of the milk –
9.  Was boiling water used to make the bottle? Yes No 
10.  What other food was use to feed the baby? 
11.  Does the mother have the clinic card? Yes No 
If yes – keep the card for the pathologist.  If no – ask the mother to bring it to the facility 
12.  Was the baby sick before it died? Yes No 
If yes  <24h >24h > 2 weeks Never 
a)  Did the baby have a cold/ runny nose? 
b)  Was the baby coughing? 
c)  Did the baby have diarrhea (runny tummy)? 
d)  Was the baby unusually restless / irritable? 
e)  Was the baby crying more than usual? 
f)  Was there a difference /change in the appetite / feeding? 
g)  Was the baby vomiting? 
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h)  Any fits / seizures? 
i)  Did the baby have a fever / showed increased sweating? 
j)  Was the baby listless?  (floppy) 
k)  Did the baby turn blue? 




14.  Did the baby come in contact with someone who is sick in the past two weeks? Yes No 
If yes – who? 
15.  Did the baby ever suddenly stopped breathing? Yes No Unknown 
16.  When was the baby’s last vaccination? 
18.  Is the baby known to be allergic to anything? Yes No Unknown 
If yes, what? 
19.  Did the family visit another country prior to the death of the baby? Yes No 
If yes, give details 
20.  Was the baby admitted to hospital in the past week before the death? Yes No 
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a) If yes, for how long and where: 
b) Why? 
c) Discharge date? 
d) Condition of baby after discharge: 
e)  Medication after discharge from the hospital (names please) 
21.  Was the baby taken to a traditional healer? Yes No 
a) If yes, date when the baby was taken to the healer: 
b) What was given? 
c) Ask for the medication to be given to the pathologist. 
d) Condition of the baby after going to the healer? 
21.  What did the baby wear when it died?  (list clothing) 
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Section F 
About the mother 
1.  Is the mother Married Single 
2.  Is the mother employed? Yes No 
3.  Age of the mother? 
4.  What standard of schooling did she achieve? 
5.  Was she on contraception before she fell pregnant? Yes No 
6.  Did she take iron and vitamin tablets during her pregnancy? Yes No 
7.  Did she receive antenatal care? Yes No 
8.  Did the mother have diabetes in pregnancy? Yes No 
9.  Did the mother have high blood pressure in pregnancy? Yes No 
10.  Did the mother gain weight adequately in pregnancy? Yes No 
11.  Was she diagnosed with any illness during the pregnancy eg. HIV? Yes No 
12.  Was the mother on any medication during the pregnancy? Yes No 
If yes, what medication:   
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13.  Were there any difficulties during the delivery? Yes No 
If yes, what? 
14.  Were there any problems with the baby after the delivery? Yes No 
If yes, what? 
15.  Was any specific instruction given about specific health care for the baby? Yes No 
If yes, what? 
16.  Was she depressed after the pregnancy? Yes No 
17.  Did she get any treatment? Yes No 
18.  How many babyren does she have? 
19.  How old are they? 
20.  Are they healthy? Yes No 
21.  Do any of the babyren have learning disability? Yes No 
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22.  Do the living babyren have the same father as the deceased baby? Yes No 
23.  Does she look after the baby? Yes No 
24.  If not, who looks after the baby? 
25.  Why is the mother unable to look after the baby? 
26.  Did the mother smoke during the pregnancy? Yes No 
If yes, how many per day? 
27.  Did the mother drink during the pregnancy? Yes No 
a)  What did she drink? Beer Wine Spirits Other 
b)  How much did she drink? Every day Now and again Weekends 
1 glass Every day Now and again Weekends 
> 1 glass Every day Now and again Weekends 
A bottle of alcohol Every day Now and again Weekends 
>  1 bottle Every day Now and again Weekends 
28.  Does she use drugs? Yes No 
a)  If yes, what drugs does she use? Tik Cocaine Heroin Mandrax Other 
b) How often does she use drugs? Every day Now and again Weekends 
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29.  Does the mother smoke after the pregnancy?  Yes No 
30.  Does the mother know that smoking harms the unborn baby? Yes No 
31.  Does the husband/partner drinks? Yes No 
32.  Does the mother drink after the pregnancy? Yes No 
33.  Do the parents of the mother drink? Yes No 
34.  Does the mother know that alcohol harms the unborn baby? Yes No 
35.  Did the mother have a previous baby that died suddenly? Yes No 
a)  If yes, how many died? 
b)  At what age? 
c)  Was a PM done?   Yes No 
If yes, where was it done? 
36.  Did the mother have a previous stillbirth? Yes No 
Section G 
Household environment 
1.  Place where the baby lives House Shack Other 
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2.  Number of bedrooms? 
3.  Is the room in which the baby was found well ventilated? Yes No 
4.  Odour(s) present in the room the baby slept in? Yes No 
5.  Peeling paint in the room the baby slept in? Yes No 
6.  Fungal growth (mould) in the room the baby slept in? Yes No 
7.  Are there pets in the house? Yes No 
If yes, type and number: 
8.  Was the following in the room where the baby slept to 
heat the room? 
Electric 
heater 
“Galley” Fire Other 
Describe other –
9.  Number of adults in the dwelling? 
10.  Number of babyren in the dwelling? 
11.  Total number of people in the dwelling? 
12.  Estimated monthly income? 
13.  Number of smokers in the dwelling? 
14.  Are there mentally retarded/ challenged people in the dwelling? Yes No 
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COMMENTS TO PATHOLOGIST FROM THE FORENSIC OFFICER WHO ATTENDED THE SCENE AND 
INTERVIEWED DURING ID PROCESS: 
ITEMS RETAINED AT THE SCENE OR FROM THE MOTHER DURING INTERVIEW 
Date: 
Signature / Thumbprint of deponent 
I certify that the above statement was taken down by myself and that the deponent has acknowledged 
that he / she knows and understands the contents hereof.  
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Supplementary material 2. Research participant consent form
Consent Form
The contribution of respiratory pathogens to Sudden Unexpected Deaths in Infancy
I have been informed of and understand the purposes of this research, possible benefits and risks.
 YES
 NO
I have been given opportunities to ask questions
 YES
 NO
I understand, I can withdraw my permission to use samples from my deceased infant for research 
purposes at any time without prejudice
 YES
 NO
I understand that the researches are under an obligation of respect to medical confidentiality; therefore 
any information which might potentially identify the deceased or any other family member will not be 
used in published material
 YES
 NO
I give permission for samples to be collected from my diseased infant during autopsy and used in 
research to investigate the contribution of respiratory infections in sudden unexpected death in infancy 




Name of Person Authorizing Consent for collection Signature Date
and use of samples for research purposes. 
------------------------------------------------------ ----------------------- -----------------------
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Name of Person Obtaining Consent for collection Signature Date
and use of samples for research purposes. 
Supplementary material 3. Research study Information sheet
Participant Information Sheet
The contribution of respiratory pathogens to Sudden Unexpected Deaths in Infancy
Good day,
My name is Elyse Sandrine Ishimirwe, and I am currently studying for a Masters degree in 
Biomedical Forensic Science at the University of Cape Town.
I would like to invite you to take part in a research study. Before you decide, you need to understand 
why the research is being done and what it would involve for you. Please take time to read the 
following information carefully. 
Aim of the research
Sudden Unexpected Death in Infancy (SUDI) is the death of infants before their first birthday that 
occur suddenly and unexpectedly by medical history. The cause of these tragic infant deaths is still 
unknown. Infections, especially of the respiratory system have been found to have a high implication. 
However, the number of investigated pathogen is still low which could underestimate the role of these 
infections. This study aims to identify the pathogens involved in these deaths and to determine the 
role of microbiological investigation in the final diagnosis.
Procedure
You are being asked to allow the following samples to be taken from your beloved one: 10 ml of 
pericardial fluid, 5 mg of lung biopsy, 10 ml of cerebrospinal fluid and 10 ml of blood sample from 
peripheral vessels. These will be collected using minimally invasive techniques during the post-
mortem examination procedure.  An identification number will be assigned to individual’s samples. 
All samples will be transported to the laboratory of Medical Microbiology Division at the University 
of Cape Town where they will be stored and further analysed. After research, the samples collected 
will be discarded of appropriately, and within 10 year-period. All personal information collected 
during this research will be treated as anonymous and confidential, and will be only used in the 
context of this research.
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Risks 
They are no risks to the deceased or the family member consenting to the use of the above named 
samples for research.
Benefits
I cannot promise the study will help you but the information we get from the study will help to 
increase the understanding of the implication of respiratory infections in sudden unexpected infant 
deaths, and possibly contribute to the improvement of diagnostic methods.
Costs/compensation
There will be no charge for participating in this research and also no payment for allowing samples to 
be collected. No samples will be used for any purpose other than the aim of this study.
Please note that:
1. Your participation is entirely voluntary and you may withdraw form this research at any time and 
for any reason, without having to give an explanation.
2. Your participation or non-participation will not affect the normal process of post-mortem 
examination.
3. The data collected will be treated securely and confidentially and stored as required by the 
University. All investigators involved in this study have signed a confidentiality agreement.
4. Results of this study will not be communicated to you, and, if published, it will be treated in an 
anonymous manner. No one will be identifiable in any data produced from this study.
5. If you have a concern about any aspect of this study, you can contact Dr. Marise Heyns (Tel.:
021 406 66 04; E-mail: marise.heyns@uct.ac.za) or Ms Elyse Sandrine Ishimirwe (Tel.: 021 406 
62 24; E-mail: ishely001@myuct.ac.za) who will do their best to answer any questions.
6. If you have any questions or concern about the safety, right and welfare of participants in human  
research study, please contact Prof. Marc Blockman, the Chairperson of the Faculty of Health 
Sciences Human Research Ethics Committee (HREC), on 021 406 63 38.
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Supplementary material 4. Research Confidentiality agreement form
Confidentiality agreement
The contribution of respiratory pathogens in Sudden Unexpected Death in Infancy
I, the undersigned, acknowledge, understand and agree to adhere to the following conditions:
∑ I will maintain the privacy and confidentiality of all accessible project data and 
understand that unauthorized disclosure of personal/confidential data is an invasion of 
privacy and may result in disciplinary, civil, and/or criminal actions against me.
∑ I will only discuss personal data or confidential information obtained in this research 
with the researches.
∑ I will use the data collected only for the purposes for which I am authorized explicitly. 
On no occasion will allow third parties to access any personal and confidential 
information.
∑ I will comply at all times with the practice’s data security policies and confidentiality 
code of conduct. 
∑ I will delete all files containing personal and confidential information from my computer 
after the completion of the research.




Supplementary material 5. Sample collection form
STORE AT - 80°C 
SUDI CASE
INFANT CASE NUMBER: ---------------------------------------
SAMPLE COLLECTED BY: ------------------------------------------------------------
FORM COMPLETED BY: ---------------------------------------------------------------
CSF: Cerebrospinal fluid
L-PNLB: left lung biopsy
PCF: Pericardial fluid
PNLB: Right lung biopsy
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Abstract
Sudden unexpected death in infancy (SUDI) is among the most frequent cause of infant mortality 
worldwide. Respiratory pathogens and bacterial toxins secreted in the upper respiratory tract are 
considered as the most frequent causal agents involved in these infants’ deaths. This review explored 
the epidemiology and diagnosis of respiratory pathogens in SUDI and the implication of associated 
risk factors. Some risk factors associated with increased susceptibility to respiratory infection are 
similar to risk factors associated with increased incidence of SUDI cases. These shared risk factors are 
associated with increased colonisation by potential pathogens or increased bacterial virulence in the 
respiratory tract, or imbalance in immunological responses to respiratory infections. Despite the 
significant role of post-mortem microbiology in the investigation of the aetiological role of various 
respiratory pathogens involved in SUDI, the diagnosis of respiratory infection in SUDI encounters 
various drawbacks associated with post-mortem microbiology and also with the lack of standardized 
protocol for selection of appropriate samples, microbiological diagnosis to be undertaken and the 
interpretation of the results. 
Keywords: sudden unexpected death in infancy, sudden infant death syndrome, respiratory 
infections, SUDI diagnosis, post-mortem microbiology, SUDI risk factors.
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1. Introduction
Sudden unexpected death in infancy (SUDI) is defined as a non-violent unexpected death of infants 
between one week and one year of age that is assessed by the absence of clinical history of diseases 1, 
2. Following in depth medico-legal investigations, only a quarter of SUDI cases is explained, thus 
referred as “explained SUDI” 1, 3, while the larger proportion (≥75%) remain uncertain, therefore 
classified as “unexplained SUDI”, also known as “Sudden Infant Death Syndrome” (SIDS) 1, 3, 4.
The diagnosis of sudden infant deaths is solely exclusive, therefore the cause of death is considered to 
be multi-factorial rather than being a result of a single cause 2, 5-7, supporting the “triple risk 
hypothesis” mechanism of death proposed by Morris et al. in 1987 8, 9. Epidemiological studies 
identified a broad range of risk factors (Table 1), including intrinsic factors, originated from the 
development of an infant 1, and extrinsic factors, related to the environment 10.
Table 1. Risk factors associated with sudden unexpected death in infancy







































*, shared risk factors between respiratory infection and Sudden Unexpected Death in Infancy (SUDI)
A number of studies have previously proposed respiratory pathogens as potential cause of death or 
acting as comorbidity factors by increasing the susceptibility to SUDI death 19, 39, 40. A high number of 
risk factors associated with SUDI are shared with risks of increased bacterial colonisation and 
occurrence of respiratory tract infections in infants and young children 5, 37, 41. Moreover, the seasonal 
patterns of most viral pathogens including Respiratory syncytial virus (RSV) 42, 43, Influenza virus 42, 43
and Human Metapneumovirus 43 exhibits a similar seasonality with incidence of cases of SUDI 12, 39, 
44, suggesting a high implication of pathogens colonizing the respiratory system in the pathogenesis of 
SUDI. 
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Investigation of infectious causes of SUDI have been the focus of forensic microbiology in the past 
years; however it presents with several drawbacks related to post-mortem body changes and the 
environment from which post-mortem examinations take place 45-47.
This review discussed the epidemiology of respiratory pathogens in SUDI and the role of specific risk 
factors associated with increased susceptibility to respiratory infections. It also addresses the 
relevance of post-mortem microbiological investigation in the diagnosis of respiratory infections in 
SUDI.
2. Burden of respiratory infections in sudden unexpected death in infancy
Respiratory infections constitute a global health threat accounting for the highest mortality and 
morbidity in children under the age of five years 48, 49. In relation to the triple risk hypothesis, 
respiratory infections are considered to be the main extrinsic triggering agents in SUDI death 2, 19, 34, 50.
An investigation of a SUDI outbreak that occurred in Iowa (US) during winter 2008, revealed that 
63% of the cases was associated with respiratory infection 51. In a retrospective study on SUDI cases 
in United Kingdom, of the 60% of explained SUDI, 20% were attributed to respiratory infection 27. In 
South Africa, about 26% of SUDI are attributed to respiratory infection regardless of the considerable 
disparity in the ancillary investigation within the country 50. 
Furthermore, signs of inflammation in the respiratory tract are frequent findings in SUDI cases 2, 52, 53. 
An autopsy study on SUDI conducted in Germany evidenced 60% signs of the upper respiratory tract 
infections 34. However, a limited number of respiratory pathogens that might be involved in these fatal 
infections have been investigated. Table 2 includes respiratory pathogens that have been detected in 
SUDI cases.
2.1 Bacterial pathogens
Bacteria are the most important causes of SUDI (Table 2) 1, 54, 55. About 80% of infectious SUDI cases 
are linked to bacteria 6, 27. The role of bacterial infection was investigated in 546 SUDI cases in South 
England (UK) 56. Of these, 39 cases were excluded due to viral or pneumocystis infections. Among 
the remaining 507 SUDI cases included in the final analysis, 72 cases were due to bacterial infection 
with the high prevalence of Staphylococcus aureus (16%) 56. In Norway, a microbiological 
investigation of 305 SUDI cases was conducted using microbial culture technique. Thirty eight cases 
were due to infections. Of 17 cases of pneumonia, 13 had a bacterial aetiology 55. Moreover, 
histopathological assessment of organs shows signs of bacterial infection  in SUDI cases compared to 
non-SUDI infant deaths 6. Furthermore, there is a correlation between epidemics of bacterial infection 
and incidence of unexplained SUDI. For instance, epidemics of Bordetella pertussis infection 
corresponds with the period of increased incidence of unexplained SUDI 57.
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The patterns of nasopharyngeal bacterial carriage differ in SUDI and non-SUDI cases. Results from 
bacterial culture of nasopharyngeal specimens indicate a higher nasopharyngeal colonisation with S. 
aureus in SUDI infants than their age matched healthy controls, especially in the first three months of 
life 21. In a study conducted in Australia, 52 SUDI cases and 102 controls were investigated. S. aureus
was found in 67% of SUDI cases and in 42% controls 40. This was also evidenced in a case-control 
study where 46 SIDS cases and 46 age-matched healthy infant controls were investigated for 
nasopharyngeal bacteria: about 41.3 % SIDS cases carried S. aureus compared to 28.3% healthy 
infants 58. A significant difference (P < 0.0001) in Streptococci carriage was observed 78.3% in SIDS 
and 32.6% in controls 58. However, the difference in nasopharyngeal and tracheal bacterial 
colonisation is not always significant as evidenced in a case-control study where about 5.1% of SIDS 
cases are colonised with B. pertussis compared to 5.3% in controls 59. Hence, the disparity in 
nasopharyngeal bacterial colonisation between SUDI cases and healthy infants requires further 
investigation to determine concomitant factors that may be involved.
2.2 Bacterial toxins 
Other than inducing infections, some bacteria isolated from SUDI cases are known to produce toxins 
which can be lethal 20, 60. A significantly higher prevalence of toxigenic strains of S. aureus was found 
in both unexplained and infectious SUDI deaths than in SUDI deaths due to non-infectious causes 61.
About 78% of S. aureus isolated from SUDI cases are toxins producers 62. Furthermore, B. pertussis
57, 59 and Haemophilus influenza 58, 63 also produces endotoxins which are involved in pathogenesis of
their respective respiratory infections. However the role of both and H. influenzae and B. pertussis 
toxins in the pathogenesis of SUDI is poorly studied.
An important feature in the lethality of bacterial toxins in SUDI deaths is their interaction with viral 
infections and sleeping conditions such as prone sleeping and overheating. Blackwell et al. 2015 
proposed that mild viral infections enhance the nasopharyngeal colonisation of toxigenic 
staphylococcal strains 41. Furthermore, it was suggested that the toxicity of bacterial toxins is 
potentiated by increased body temperature in case of mild viral infections and prone sleeping 41, 64, 65.
It is also noteworthy to mention that bacterial toxins isolated from the infant’s nasopharyngeal have 
the ability to potentiate the toxigenicity of one another 66.
The well-known hypothesis that explains the role of bacterial toxins in the occurrence of SUDI is 
called “common bacterial hypothesis”, proposed for the first time by Morris and colleagues in 1987 26.
According to the “common bacterial hypothesis”, SUDI deaths are induced by bacteria producing 
toxins that inhabits the upper respiratory tract 67. However, a number of toxigenic bacteria that 
colonise mainly the gastro-intestinal tract have been also associated with SUDI 5, 68. Therefore, 
nasopharyngeal carriage of toxigenic bacteria should be considered as a potential cause of death in the 
diagnosis of SUDI cases.
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2.3 Viral pathogens 
Respiratory viral pathogens have been implicated in the occurrence of SUDI 2, 5, 69. It has been shown 
that infants with a mild viral infection are at higher risk of SUDI 26. The incidence of SUDI exhibits a 
close correlation with the increased prevalence of viral pathogens of the airways, such as respiratory 
syncytial viruses (RSV) and influenza viruses 1, 2, 12.
A number of viruses have been associated with SUDI, mainly RSV, influenza viruses, herpes simplex 
virus (HSV), cytomegalovirus (CMV) and adenovirus (AdV) 2, 11, 19, 51, 70. Using Immunofluorescence 
and cell culture techniques, 18 cases of SUDI attributed to viral infection were identified in post-
mortem lung tissue samples from 490 SUDI cases in a study conducted in UK 2. The detected viruses 
in the latter study included: enterovirus (n= 4), RSV (n= 4), HSV (n= 3), CMV (n= 3), AdV (n= 1), 
Influenza virus (n= 1) and human immunodeficiency virus (n= 1) 2. A virological surveillance of lung 
tissues conducted as part of medico-legal investigation of SUDI cases in Western Cape, South Africa, 
demonstrated a high burden of CMV (29/82,35%) colonisation compared to the low detection rate of 
AdV (2/82, 2,44%) and RSV  (4/82,4.88%) 19. This low detection rate of AdV and RSV is in contrast 
with the high incidence rate of both viruses in cases of SUDI worldwide. CMV was detected using all 
the three detection methods under study, including shell vial culture, real-time PCR and 
immunohistochemistry. Yet, only real-time PCR detected positive cases of AdV and only 
immunohistochemistry yield positive results for RSV 19. The disparity in virological results from 
different diagnostic techniques evidenced in the study of Burger et al.19 demonstrated also the impact 
of viral detection methods in the diagnosis of SUDI.
Besides the detection of single viruses, it has been shown that SUDI can be also a result of multiple 
infections 51, 70. Following PCR-based virological investigation of a SUDI case, a CMV and Varicella-
Zoster virus co-infection was detected in heart, lung, small intestine and colonic samples. The highest 
CMV load was observed in the lungs 70. Additionally, a RSV and influenza virus co-infection was 
also detected in nasopharyngeal specimens from a SUDI case 51. 
The incidence of respiratory viruses from case-control studies present disparity results 71, 72. Formalin 
fixed tissues from 11 SUDI cases and nine controls were analysed for the detection of human 
herpesvirus-6 (HHV-6), Epsein-Barr virus (EBV) and CMV using real-time PCR. The incidence of 
CMV, EBV and HHV-6 combined was 72.2% in SIDS infants and 22,2% in previously healthy 
infants died of non-infectious causes 72. The viral load for CMV was significantly higher in SIDS 
infants (45.3 DNA copies/µg) than in controls (20.5 DNA copies/µg) 72. However, a non-significant 
difference (p= 0.18) was observed between the prevalence of both AdV and Rotavirus in SUDI (30%)
and age-matched controls (20%) 71. Hence, as respiratory viruses also occur in healthy infants, their 
role in the pathogenesis of SUDI either as cause of death or contributing factors requires further 
investigation. 
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2.4 Fungal pathogens 
Pneumocytis jirovecii colonisation is a common finding in children dying suddenly and 
unexpectedly73, 74 and the age peak of Pneumocytis infection ranging from three to four months is 
similar to the SUDI critical age period, which ranges from two to four months of life 11, 12. P. jirovecii
was detected in 82% of sudden unexpected deaths 73. However, this organism has been also found in 
apparently healthy infants of less than one year of age 75, and its role in  SUDI deaths is yet to be 
defined.
3. Risk factors associated with respiratory pathogens in sudden unexpected death in
infancy
The recent work by Blackwell et al. summarized in details risk factors of SUDI and their role in 
inflammatory responses to infection 76. A number of risk factors of SUDI are associated with 
increased susceptibility to respiratory infections (Table 1) 76. Following epidemiological surveys, 
evidence of pathological signs of infection in the respiratory tract or detection of respiratory 
pathogens have been found to be associated with some genetic, immunological and environmental 
factors 23, 38, 76.   
3.1 Critical developmental period
A decrease in maternal antibody is observed during the critical development period ranging from two 
to four months of life 10, 11. During this critical period, infant’s immunity is at a developmental stage
11. Moreover, the immunization process supposed to assist the infant’s immunity and therefore reduce 
risks of SUDI is yet to be completed 77-80. This immunological imbalance observed during the critical 
developmental period renders infants more susceptible to new infections.
3.2 Inflammatory responses
The immunological imbalance associated with cytokines levels increase the vulnerability of infants to 
both infections and unexplained SUDI.11, 23, 38. In cases of CMV infection, which is often detected in 
SUDI cases 2, 19, 70, 72, 81, infants showed a significant reduced level of interferon γ, interleukin II and 
CD154 production and differentiation 82. In a mice model of respiratory infection, a late development 
of CD8+ T cell responses was observed in cases of HSV infection 83, which is also a common virus 
associated with SUDI 2, 72, 81, 84.
The level of Interleukin (IL) 10, the cytokine involved in protection against staphylococcal 
enterotoxin induced shock 85 has shared factors with SIDS including cigarette smoking, male gender 
and ethnicity 5. Furthermore, IL polymorphisms have been found to influence the effects of cigarette 
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smoke exposure in infants 5 which indicates that the levels of specific cytokines may constitute a 
contributing factor to SUDI.
A further support for the theory of inflammatory responses in SUDI cases is the evidence of 
histological signs of inflammation in respiratory organs 44, 86-88. A common histological sign 
in SUDI is intrathoracic petechial haemorrhage suggested to be a result of infant’s efforts to 
overcome hypoxia and respiratory difficulties 44, 89. About 55% of explained SUDI and 90% 
of SIDS presents petechial haemorrhages at least in one of intra-thoracic organ 27. More,
inflammatory changes in the laryngeal epithelium have been significantly associated with 
SIDS suggesting that some SIDS deaths involve preceding inflammation in the respiratory 
tract 88. However, since some inflammatory signs are not restricted to respiratory infection in 
SUDI, further studies on the inflammation of respiratory origin and SUDI is important. The 
interaction between imbalance in the immunological responses to respiratory infection, 
histopathological signs of inflammation in the respiratory organs and other environmental 
risk factors for SIDS may indicate that respiratory infections play a major role in the 
pathogenesis of SUDI. 
3.3 Genetic disorders
Genetic alterations and their subsequent pathogenic role constitute an innate risk factor to unexplained 
SUDI 8, 22. A number of genes have been implicated, mainly genes involved in the respiratory 
regulation or those that have a physiological correlation, causing inherited diseases 8, 34. The deletion 
of either complement C4A or C4B genes increases the vulnerability to unexplained SUDI in infants 
with mild respiratory infections 23, 24. Gene polymorphisms determine the effectiveness of cytokine 
responses 23. IL 10 polymorphisms have been associated with both severity of respiratory infections 90
and unexplained SUDI 91, 92. The effects of IL 10 polymorphism are more prominent in cases of 
maternal smoking both during pregnancy and breastfeeding 23.
3.4 Sex
An increased incidence of SUDI is observed in male infants compared to females 8, 15, 38. During the 
first six months of life, the levels of testosterone increases in male infants compared to females. This 
period of increased testosterone levels in male infants corresponds to the period of high incidence of 
SIDS 12, 93. Moreover, a positive correlation was observed between testosterone levels and pro-
inflammatory responses to lipopolysaccharides in cells previously treated with interferon-Y 12. Hence, 
the rise in testosterone levels in male infants may alter immunological responses to respiratory viral 
infections in male infants.
61
Table 2. Respiratory pathogens associated with sudden unexpected death in infancy
Microorganisms Sample types Detection methods References
Adenovirus Lungs RT-PCR 19
NPS NA 51
Lungs, bronchi and faeces Culture and PCR 84
Lungs PCR 2
NS and URT aspiration IF 44
Lungs Culture 81
Cytomegalovirus Lungs SVC, RT-PCR, IHC 19
Kidneys and lungs IHC 70
All tissues RT- PCR 70
Lungs PCR/DEAFF/ Culture 2
Lungs, brain, kidney and spleen RT-PCR 72
Sera, CSF, tissue samples and body fluids Complement fixation 81
Influenza virus NPS NA 51
Lungs IF 2
Sera, CSF, tissue samples and body fluids Compliment fixation 81
Parainfluenza virus Lungs, bronchi and faeces Culture and PCR 84
Lungs, bronchi and faeces Culture and PCR 84
NS and URT aspiration IF 44
Respiratory Syncitial Virus Lungs IHC 19
NPS NA 51
Lungs, bronchi and faeces Culture and PCR 84
Lungs IF 2
NS and URT aspiration IF 44
All tissues RT-PCR 70
Herpes simplex virus Lungs, bronchi and faeces Culture and PCR 84
Lungs PCR 2
Spleen Culture 2
PE lungs, brain, kidney and spleen RT-PCR 72
Pharyngeal aspirate and nasal washing Nested PCR 81
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Table 3. Respiratory pathogens associated with sudden unexpected death in infancy (continue)
Microorganisms Sample types Detection methods References
Bordetella pertussis NPS and TS Conventional PCR 94
FFPE tranchea, larynx, bronchi and lungs IHC 94
Haemaphilus influenzae NPS NA 51
Heart blood, CSF, NPA, swabs from 
relevant tissues
Microscopy, Culture and 
PCR
84
Heart blood, spleen, CSF and lungs Culture 54
Heart blood, lungs and kidney Culture 55
Blood, liver, lungs, heart, spleen, 
kidneys, meninges, choroid plexus and 
bladder
Culture 44
Mycobacterium tuberculosis Lung and nodes ZN staining 95
Staphylococcus aureus NPS NA 51
PM samples Culture
Heart blood, CSF, NPA, swabs from 
relevant tissues
Microscopy, Culture and 
PCR
84
Heart blood, CSF and lungs Culture 54
Heart blood Culture
Blood, liver, lungs, heart, spleen, kidney, 
meninges, choroid plexus and bladder
Culture 55
Streptococcus pneumoniae NPS NA 51
Heart blood, CSF, NPA, swabs from 
relevant tissues
Microscopy, Culture, PCR 84
Heart blood, spleen, CSF and lungs Culture 54
Heart blood Culture 55
Klebsiella pneumoniae Heart blood, CSF, lungs, liver, kidneys 
and spleen 
Culture 55
Pneumocytis jiroveci Lungs Nested PCR 73
Lungs Microscopy 75
PE lungs NA 74
CSF: cerebrospinal fluid, DEAFF: detection of early antigen fluorescent foci for CMV, EM: electron 
microscopy, FFPE: formalin –fixed, paraffin-embedded, IF: immunofluorescence, IHC:  
immunohistochemistry, NA: not specified, NPA: nasopharyngeal aspirates, NPS: nasopharyngeal 
swabs, NS: Nasal swabs, PCR: polymerase chain reaction, PM: post-mortem PE: paraffin-embedded, 
RT-PCR: real-time polymerase chain reaction, SVC: shell vial culture, TS: tracheal swabs, URT: 
upper respiratory tract, ZN: Ziel-Neelsen.
3.5 Non-safe Sleeping behaviour 
Prone sleeping is the most recognised SUDI risk factor 13, 14, 96. It is suggested that unexplained SUDI 
results from heat responses especially in the first six months of life 97. In case of prone sleeping and 
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mild viral infection, the rise in body temperature leads to increased bacterial colonisation and 
enhances bacterial toxin production in the upper respiratory tract 6, 98. The nasopharyngeal 
colonisation with S. aureus is considerably higher in infants who are put down to sleep in a prone 
position 98. Non-recommended sleeping behaviour such as prone sleeping, overheating, bed sharing 
predispose infants to thermal stress and potentiate bacterial toxins production in the upper respiratory 
tract 10, 13.
3.6 Lack of Breastfeeding
Breast milk, as a core component in the development of infant’s immune defence mechanisms, plays 
an important role in both protection against viral respiratory infections 30, 99 and SUDI 28. A lower 
incidence rate of SUDI has been reported in breastfed infants compared to their counterparts 28.
The role of breastfeeding in reducing the severity of respiratory infections is linked to the effect of 
breast milk in cytokines production 29. Melendi et al. reported high levels of Interferon type 1 
associated with breastfeeding in case of viral infections frequently reported in SUDI cases such as 
Influenza virus infection 29. At the same time, secretory IgA maternal antibodies and other factors 
including bactericidal lactoferrin that infants receive from breast milk protects the mucosal 
membranes infants, therefore protects breastfed infants against respiratory infections 100.
3.7 Exposure to cigarette smoke
Parental smoking highly increases the risk of unexplained SUDI 6, 34. Prenatal smoke exposure alter 
the normal development of lungs leading to the impairment of respiratory functions 6, 34. Moreover, 
postnatal parental smoking was found to be an important environmental risk factor for SIDS 101.
Adult smokers were found to be more densely and more frequently colonised by bacteria causing 
respiratory infections including Streptococcus pneumoniae, H. influenzae, Moraxella catarrhalis 36
hence infants exposed to cigarette smoking parents are more exposed to infectious agents from their 
highly and frequently bacterial colonised parents. Other than that, Heininger et al. demonstrated that 
nicotine predisposes infants to respiratory infections 59. The study by Sayers et al. showed that in 
chick embryos, very low concentrations of nicotine enhances the toxigenicity of bacterial toxins 
associated with SIDS 35.
3.8 Viral infections
In general, viral infections alter the normal microbial flora which lead to bacterial overgrowth and 
toxin production 26. Viral infections increase also body temperature which leads to toxin production 76. 
In mice infants, epithelial cells infected with RSV showed a greater susceptibility to S. aureus
invasion compared to non-infected cells 25. Further, Zhang et al. demonstrated that influenza A 
infection potentiate staphylococcal enterotoxin B 102. The administration of staphylococcal enterotoxin 
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B in transgenic mice infected with a sub-lethal dose of influenza A, resulted in death in all mice 102.
Yet, S. aureus is considered as the main bacterial cause of respiratory infection in SUDI 54, 55, 84.
4. Microbiological investigation of respiratory infections in sudden unexpected death in 
infancy
An aetiological diagnosis of respiratory infection in SUDI cases is based on post-mortem 
microbiological investigation. However, challenges around the value and procedures in post-mortem 
microbiology render the interpretation of results less easy. 
4.1 Post-mortem microbiology
Post-mortem microbiological investigation aims to determine microbial colonisation prior death 61, 84.
Morentin et al. describes the importance of post-mortem microbiology in sudden unexpected death as 
a valuable tool in the identification of emerging infections 45. Post-mortem microbiology not only has 
an epidemiological value but, it also has a huge importance in medico-legal investigations 52, 55, 103.
Post-mortem microbiology is a compulsory ancillary investigation technique in the investigation of 
SUDI cases 55. It however presents with several drawbacks 1, 46, 55:
- Agonal spread 47 defined as the invasion of bacteria through the mucosal surface following 
ischaemia and /or hypoxia during the process of dying. However, the process of agonal spread 
does not always occur 46.
- Bacteria migration from the mucosal surface into the blood and body tissues after death, 
known as post-mortem bacterial translocation 47. This can be reduced by cooling the bodies 
below 6°C prior to post-mortem examination 47, 55. Microbiology findings were proven to be 
constant in the first 48 hours of death 55, 61.
- Contamination of the specimens 46 is a major artefact in post-mortem microbiological 
investigation. Specimens are usually collected during autopsy in mortuaries which are highly 
contaminated environments.
Several methods of improving post-mortem microbiological investigation were suggested, such as a 
sampling strategy consisting of prioritizing sample collection before open autopsy and starting from 
body fluid, followed by tissues with rigorous aseptic techniques, all within 48 hours after death to 
reduce risks of contamination 46, 47, 55.
Detection methods used in microbiological investigation significantly impact the findings and the 
perceptions on the role of respiratory pathogens in SUDI.  An enormous variation is observed in 
microbial culture-based methods, routinely used in post-mortem microbiology 1, 47, 104. More 
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importantly, culture-based methods only detect viable organisms and are known to have a low 
sensitivity 19, 47, 104. This is a limiting factor in microbiological investigation of SUDI deaths, where 
samples are taken several hours to days after death and the corpse have been put into conditions that 
might be unfavourable for some microorganisms. Alternative molecular diagnostics techniques are 
known to have a higher sensitivity and specificity hence increase reliability of microbiological 
findings 1, 72, 73, 104.
Furthermore, because of the lack of published guidelines, the interpretation of post-mortem 
microbiology findings is difficult 47. A number of respiratory pathogens involved in SUDI cases are 
also found in healthy controls (Table 3) 40, 58, 71. Different specialists involved in the medico-legal 
investigation of SUDI do not have a consensus as to the interpretation of microbiological findings 61.
Professional microbiologists or a collaborative work between microbiologists and forensic scientists 
could provide a better interpretation of post-mortem microbiology results 54, 104. Pryce et al. suggested 
that microbiological findings should be supported by significant histopathological findings for it to be 
relevant in the final diagnosis 61. However, SUDI cases might have an infectious aetiology without 















































































































































































































































































































































































































4.2 Diagnosis of respiratory infection in SUDI
A variety of specimens have been used in the investigation of respiratory pathogens in cases of SUDI, 
these include but not limited to body fluids (blood, pleural fluid, cerebrospinal fluid), spleen, liver, 
nasopharyngeal swabs, nasal swabs, bronchi and lung tissues. Lung tissue has been a recommended 
sample in medico-legal investigation of paediatric cases; and also believed to be the ideal sample in 
diagnosing respiratory infections 105. However, lung tissues are susceptible to contamination 47, 55, 105. 
About 50% of lung biopsies collected during autopsy are found to be contaminated 105. The high risk 
of contamination of lung tissue samples during collection renders more difficult to interpret the results 
especially in case of multiple pathogen detection, which is common in SUDI cases. Therefore, a broad 
range of samples and sampling procedures should be investigated before a conclusive identification of 
ideal sample sites for post-mortem microbiological investigation can be proposed.
Despite major advances in diagnostics techniques, differentiating true pathogens and commensal 
microorganisms from non-sterile sample site (nasopharyngeal swabs, nasal swabs) have been a major 
problem in the diagnosis of respiratory infection not only in post-mortem samples but also in living 
individuals 105, 106. Alternatively, normally sterile, especially those located at the infection focus 
(bronchi, lung biopsy and pleural effusion) have a better diagnostic value as the detection of potential 
pathogen in otherwise normally sterile site is considered as the aetiological cause of infection 54, 104, 
107, therefore a potential cause of death. 
5. Perspectives
The routine screening for respiratory pathogens in SUDI cases using very sensitive assays would be of 
great interest because it will not only allow the identification of the known pathogens associated with 
SUDI but it will also surely allow the identification of new pathogens contributing to SUDI. This 
approach will be essential in the elaboration of preventive strategies against this fatal illness. 
Microbiological investigation of SUDI cases should be improved and be standardized at least within 
countries to enable proper monitoring. This has to include ideal sample site, sample collection 
methods, diagnostics techniques to be undertaken and also guidelines for results interpretation. 
Most of the studies on the aetiology of respiratory infections in SUDI used a pathogen-target approach 
which does not allow for the diversity of microbial community 2, 19, 70, 72. More studies are needed to 
identify pathogens to be included in the routine investigation of SUDI deaths. Since some pathogens 
detected in SUDI are also found in non-SUDI cases, more case-control studies should be conducted. 
Advanced diagnostic techniques that allow rapid and accurate detection methods such as  MALDI-
TOF (matrix-assisted laser desorption ionisation time-of-flight) mass spectrophotometry for fungi and 
multiplex PCR reactions for viral, bacterial and fungal organisms 108, 109 could be valuable for 
screening respiratory pathogens in cases of SUDI.
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Abstract
Background: Sudden unexpected death in infancy (SUDI) is among the most frequent causes of 
mortality in infants less than one year of age. Respiratory infections have been identified as the most 
frequent cause of death in these infants. Yet, the broad range of respiratory pathogen that might be 
involved in SUDI is poorly studied. This study aimed to investigate the incidence of the respiratory 
pathogens in SUDI. 
Methods: A prospective study was carried out on SUDI cases admitted to Salt River Forensic 
Pathology Laboratory from February 2015 through May 2015. Cerebrospinal fluid, pericardial fluid 
and lung biopsy were collected from each study participant during post-mortem examination. Total 
nucleic acids were extracted on the automated QIAsymphony platform. The microbial diversity was 
investigated using a commercialized multiplex real-time PCR assay, the “FTD Respiratory pathogens 
33” kit. This assay is able to detect 21 viruses, 11 bacteria and one fungus. In each real-time PCR run, 
a positive and non-template sterile water were included as controls. 
Results: Thirty SUDI cases (median age, 3 (interquartile range (IQR):  2 – 8 months) were included 
in the study. Twenty participants were males. Positive microbiological results from at least one of the 
three samples were obtained in 28 cases (93%). According to the type of sample, respiratory 
pathogens were detected in almost all the lung biopsies (93%), while it was only detected in 60% and 
50% of the cerebrospinal and the pericardial fluids, respectively. The median cycle threshold value 
was lower in lung biopsies (30 (IQR: 28 ‒ 35)) compared to both cerebrospinal (34 (IQR: 30‒ 36)) 
and pericardial fluids (35 (IQR: 33‒ 35)) (p= 0.039). In lung biopsies, the most commonly detected 
bacteria were K. pneumoniae (47%, 14/30) and M. catarrhalis (20%, 6/30). H. influenzae (7%, 2/30) 
and M. pneumoniae (7%, 2/30) were the bacteria often detected in pericardial fluid and cerebrospinal 
fluid, respectively. Human Metapneumovirus was the most frequently virus detected in all three 
sample types assessed, accounting for 33% (10/30) in cerebrospinal fluid, 37% (11/30) in pericardial 
fluid and 57% (17/30) in lung biopsy samples, respectively. A single type of pathogen was detected in 
seven of the 28 positive cases.
Conclusion: This study highlights the potential implication of respiratory infection in SUDI and it 
reports one of the highest incidences of respiratory pathogens in SUDI cases. In addition, it is the first 
to report the high incidence rate of Human Metapneumovirus in SUDI cases. The findings also 
showed that the majority of SUDI cases are associated with synergetic interaction of multiple 
respiratory infections. However, data related to histopathology and bacterial culture were not 
available. A broad range of respiratory pathogens should be included in the routine investigation of 
SUDI cases with more sensitive diagnostic methods. 
Key words: respiratory pathogens, respiratory infection, sudden unexpected death in infancy, real-
time PCR, post-mortem microbiology.
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1. Introduction
Sudden unexpected death in infancy (SUDI) is the leading cause of post-neonatal mortality in 
developed countries accounting for over than 50% of all infant death 1-5. In Africa, all the reported 
data came from studies conducted in South Africa 6-9, where SUDI comprises 3.3% of all medico-
legal autopsy cases admitted to forensic mortuaries 6. However, the disparity in the investigative 
procedures renders it difficult to establish national statistics.
Following microbiological investigation, respiratory pathogens and subsequent pathological signs in 
the respiratory organs have been found to contribute to SUDI 6, 10, 11. Nasopharyngeal and gastro-
intestinal samples from SUDI cases were found to be colonised by more potential bacterial pathogens 
such as Staphlylococci and Streptococci than their age matched controls 12-14.  Also, viral pathogens 
have been identified as a direct cause of death or playing the role of enhancing the invasion of 
bacterial pathogens or bacterial toxins production 15-18. In addition, SUDI exhibits a similar 
seasonality to epidemic viral infections, such as Influenza 19, 20 and Human Metapneumovirus 19.
However, the majority of respiratory pathogens remains undetected due to less sensitive or specific 
diagnostic techniques or simply is not included in the investigation.
Identification of the pathogen spectrum in infants that die suddenly and unexpectedly would help in 
the elaboration of preventive methods and would serve as an approach to the identification of
microbial pathogens to be included in the standard microbiological investigation in cases of SUDI. 
This study serves as an initial evaluation of the incidence of a wide range of selected respiratory 
pathogens. 
2. Materials and methods 
2.1 Ethical approval
The study protocol was approved by the human research ethics committee of the University of Cape 
Town, South Africa (HREC 635/2014). Written informed consent was obtained from the parents or 
the legal guardians of each study participant prior to the sample collection.
2.2 Participants and study design
This prospective study enrolled all the consecutive SUDI (sudden unexpected death in infancy less 
than one year of age) cases admitted to Salt River Forensic Pathology Laboratory (Cape Town, South 
Africa) over a four months period, from February 2015 through May 2015. Salt River Forensic 
Pathology Laboratory is an academic forensic laboratory that serves the Cape Town western 




Post-mortem examination was performed by forensic pathologists. It follows the routine protocol of 
post-mortem examination at the study setting that consisted of an external examination of the body, a 
full-body imaging and a review of the clinical history. Full-body radiology was performed using 
Lodox® scanners, the Lodox® Statscan® or Lodox® Xmplar-dr® (Lodox® Systems, Johannesburg, 
South Africa) according to the manufacturer’s instructions. This new digital imaging technique 
provides a full-body radiological image and detects both soft and hard tissue abnormalities 7, 21. 
Characteristics of the study participants were retrospectively obtained from a questionnaire 
administered to the parents or guardians of the deceased infant during the process of body 
identification as per standard procedure at Salt River Forensic Pathology Laboratory (Cape Town, 
South Africa). Data was entered into a SPSS spreadsheet (SPSS Statistics for windows, version 22.0, 
Chicago, IL, USA).
2.4 Sample collection
Before opening the body, cerebrospinal fluid was obtained by sub-occipital puncture. After opening 
the thorax, pericardial fluid was obtained by a puncture to the pericardial sac. Thereafter, lung 
biopsies were obtained from both left and right lungs. All the above mentioned samples were 
collected under rigorous aseptic conditions consisted of skin surface decontamination by 70% ethanol 
and changing gloves between each sample type. All the above mentioned samples were collected in 
sterile 2ml Sarstedt tubes (Qiagen, Hidden, Germany). Collected samples were put into an ice box and 
transported immediately to the Division of Medical Microbiology at the University of Cape Town 
(Cape Town, South Africa) where it was kept at - 80°C prior to processing.
2.5 Respiratory pathogens detection by multiplex real-time polymerase chain reaction 
The detection of respiratory pathogens was performed at the Division of Medical Microbiology, 
University of Cape Town, South Africa. The laboratory at the Division of Medical Microbiology 
includes a well-equipped molecular biology unit, with the unidirectional principle respected. Safety 
practices are strictly enforced following established operation protocols outlined in a biosafety manual 
by the Institute of Infectious Diseases and Molecular Medicine (University of Cape Town, South 
Africa).
2.5.1 Total nucleic acids extraction
Samples to be tested were thawed at room temperature (22°C). Total nucleic acids were extracted 
using the QIAsymphony® DSP virus/ Pathogen Mini Kit (Qiagen, Hidden, Germany) on the 
automated QIAsymphony platform (Qiagen, Hidden, Germany) using the complex cell free 200V5 
virus application protocol according to the manufacturer’s instructions. Total nucleic acids were 
extracted from a starting volume of 300µl and eluted in a final volume of 60µl. The extracted nucleic 
acids were stored at -70°C until further analysis.
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For lung biopsy, a pre-extraction step was undertaken in a biosafety hood: lung biopsy was crushed 
with a manual hand crusher in normal saline. After proteinase K and ATL tissue lysis buffer treatment 
(25mg/25µl, 25mg/375µl; 37°C for 24 hours), the supernatant was used for nucleic acids extraction as 
described previously.
2. 5.2 Multiplex real-time polymerase chain reaction
Real-time amplification for 33 respiratory microorganisms commonly associated with respiratory 
infections (Table 1) was performed on the BioRad CFX96TM real-time PCR instrument (Bio-Rad, 
Hercules, Calfornia, US) using the FTD respiratory pathogens 33 Kit (Fast-Track diagnosis, 
Junglinster, Luxembourg) as per the manufacturer’s recommendations, with minor changes. The real-
time PCR reactions were performed in 12.5µl volumes instead of the 25µl as recommended by the 
manufacturer. The FTD respiratory pathogens 33 real-time PCR protocol has eight multiplexes per 
sample (Table 1). Each PCR reaction consisted of 5µl of the extracted nucleic acids, 6.25µl of the 
2×real-time PCR buffer, 0.75µl of primer/probe mix and  0.5µl of enzyme mix (AgPath-IDTM one-
step RT-PCR kit, Applied Biosystems, Carlsbad, CA, USA). The thermal cycling was performed 
using the following parameters: initial denaturation at 95°C for 10 min, followed by 40 amplification 
cycles of 94°C for 8 sec and 60°C for 34°C sec. To monitor the assay performance, negative and 
positive controls were included in each run. An internal control (equine arteritis virus) provided in the 
kit, was included in all samples to monitor nucleic acids extraction and amplification process. 
Positive results were indicated by an exponential amplification curve that crossed the threshold cycle 
within 40 cycles. Amplification data analysis and interpretation were performed using the FTD resp. 
33 Analyser software version 1.0 (Cape Town, South Africa) according to the manufacturer’s 
instructions (http://www.gematics.com/analyser.html).
Table 1. Microorganisms targeted in the FTD respiratory pathogens 33 kit
Reaction number Reaction name Organism-targeted
1 FluAB-RH Influenza virus A and B, and Rhinovirus
2 Para.EAV Parainfluenza 2,3,4 and Internal control (Equine arteritis virus)
3 Cor Coronavirus NL63, 229E,C433 and HKU1
4 BoMpPf1 Parainfluenza 1, Human metapneumovirus A/B, Bocavirus and 
Mycoplasma pneumoniae
5 RsEPAcmv Respiratory syncytial viruses A/B, Cytomegalovirus, Adenovirus, 
Enterovirus and Parechovirus
6 Bac Chlamydia pneumoniae, Streptococcus pneumoniae, Haemophilus 
influenzae type B and Staphylococcus aureus
7 KLePSa Klebsiella pneumoniae, legionella spp., Salmonella spp. and Pneumocystis 
jirovecii




Descriptive analyses are expressed as median and interquartile range for continuous variables and 
number (percentage) for categorical variables. Logit analysis model was done using Fisher’s exact or 
Likelihood ratio where applicable. Agreement between pathogen detection results and full body 
radiology results was evaluated with Cohen’s kappa (k) statistics. All statistical analyses were done 
with SPSS for windows, version 22.0 (Chicago, IL, USA). In all statistical analyses, p values less than 
0.05 were considered statistically significant.
3. Results
3.1 Characteristics of study participants
Thirty SUDI cases were included in this study, 20 (67%) males and 10 (33%) females. The median 
age was three months (interquartile range (IQR) 2 - 8 months). Most of the cases were of African
ancestry (50%, 15/30) and of mixed race ancestry (40%, 12/30). The vaccine coverage pattern among
the study participants was 83% (25/30). 
Of the study participants, 64% (16/25) died in bed whilst asleep (Table 2). About two-third (61%), 
11/18) of infants were exposed to cigarette smoke on a daily basis. The median number of smokers in 
the dwelling was two (IQR, 1 – 2 persons). The median age of the infant’s mothers was 26 years 
(IQR, 21 – 32 years) and the majority of infant’s mothers (83%, 20/24) were unemployed. The only 
characteristic of the mothers that was statistically associated with unexplained SUDI death was 
marital status (p-value = 0.028) (Table 3). 
3.2 Post-mortem examination findings
The median post-mortem interval was three days (IQR, 2 - 4 days). From the 30 SUDI cases 
examined, 24 (80%) were explained SUDI and six (20%) unexplained. Of the 24 explained SUDI, 14 
(58%, 14/24) had apparent lung pathology consistent with lower respiratory tract infection (Figure 1). 
The main pathological sign of lower respiratory tract infections observed on full-body radiological 
imaging was bilateral lung opacities (4/18, 22%) (Figure 2). 
3.3 Microbiological findings
3.3.1 Real-time PCR data using the Fast-track Diagnostics® kit
Microbiological analysis revealed the presence of a potential pathogen in 93% (28/30) of the SUDI 
cases. Most of the respiratory pathogens assessed were detected in the lung biopsies (93%, 28/30), 
followed by the pericardial fluid (63%, 19/30) and the cerebrospinal fluid (47%, 14/30). According to 
the sample type, the median cycle threshold value was lower in lung biopsy samples (30 (IQR: 28 ‒ 
35)) compared to both cerebrospinal fluid (34 (IQR: 30 ‒ 36)) and pericardial fluid (35 (IQR: 33 ‒ 
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35)) samples. The median cycle threshold value was significantly different among the three samples 
(P= 0.039). There was 60% (18/30) positive SUDI cases that involved at least one bacterial pathogen, 
73.3% (22/30) involved at least one viral pathogen, and 50% (15/30) involved Pneumocystis jirovecii. 







< 2 months 8 (66.7%) 4 (33.3%) 12
2 ‒ 4 months 8 (82.4%) 0 (17.6%) 8
>4 months 8 (85.7%) 2 (14.3%) 10 
Gender (n=30) 0.372
Male 17 (85%) 3 (15%) 20
Female 7 (70%) 3 (30%) 10
Prematurity (n=27) 1
Preterm 7 (87.5%) 1 (12.5%) 8
Born at term 15(78.9%) 4 (21.1%) 19
Race (n=27) 1
African 12 (80%) 3 (20%) 15
Mixed race 10 (83.3%) 2 (16.7%) 12
Feeding practice (n=28) 0.492
Breastfeeding 10 (76.9%) 3 (23.1%) 13
Formula feeding 10 (83.3%) 2 (16.7%) 12
Both breast and formula feeding 3 (100%) 0 3
Birth weight (n=27) 1
Low (< 2500g) 8 (80%) 2 (20%) 10
Normal (≥ 2500g) 14 (82.4%) 3 (17.6%) 17
Vaccination status (n= 30) 0.254
Vaccination  status up to date 21 (84%) 4 (16%) 25
No vaccination records 3 (60%) 2 (40%) 5
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Table 2. Demographic and background characteristics of SUDI cases (continue)
Characteristics
Number (percent)
Total P-valueexplained SUDI unexplained SUDI
Place of death (n=25) 0.312
Bed 14 (87.5%) 2 (12.5%) 16
Couch 1 (100%) 0 (0%) 1 
Mother’s arm 1 (33.3%) 2 (66.7%) 3 
Unknown 4 (80%) 1 (20%) 5 
Sleeping position at death (n=23) 0.539
Supine 5 (100%) 0 (0%) 5 
Prone 4 (66.7%) 2 (33.3%) 6 
Side 8 (88.9%) 1 (11.1%) 9
Unknown 2 (66.7%) 1 (33.3%) 3 
Face position at death (n=23) 1
Face up 2 (100%) 0 (0%) 2 
Face down 1 (100%) 0 (0%) 1 
Face to the side 6 (60%) 4 (40%) 10 
Other (unknown) 5 (100%) 0 (0%) 5 
Bed sharing (n=27) 1
Yes 22 (84.6%) 4 (15.4%) 26 
No 1 (100%) 0 (0%) 1 
Smoking while baby is sleeping (n=21) 1
Yes 6 (85.7%) 1 (14.3%) 7 
No 11 (78.6%) 3 (21.4%) 14 
Presence of smokers in the dwelling (n=17)
Yes 9 (81.8%) 2 (18.2%) 11 1
No 5 (83.3%) 3 (16.7%) 6 
SUDI, sudden unexplained death in infancy; n, total number tested.
Human Metapneumovirus A/B was the most common pathogen detected, accounting for 33% (10/30) 
in cerebrospinal fluid, 37% (11/30) in pericardial fluid and 57% (17/30) in lung biopsy. The most 
frequently detected bacteria was Klebsiella pneumoniae (47%, 14/30) in lung biopsy, Moraxella 
catarrhalis (10%, 3/30) and K. pneumoniae (10%, 3/30) in pericardial fluid, and Mycoplasma 
pneumoniae (7%, 2/30) in cerebrospinal fluid. P. jirovecii was more commonly detected in lung 
biopsies (47%, 14/30). Adenovirus (AdV), Cytomegalovirus (CMV), Respiratory syncytial virus 
(RSV), and Bortdella pertussis were not detected in this study (Figure 3).
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Table 3. Characteristics about the mother of the infants
Characteristics
Number (percent)
P-valueexplained SUDI unexplained SUDI
Total
Marital status (n=26) 0.028
Married 1 (25%) 3 (75%) 4
Single 19 (86.4%) 3 (13.6%) 22
Employment status (n=24) 0.544
Employed 4 (100%) 0 (0%) 4
Unemployed 15 (75%) 5 (25%) 20
Education status (n=20) 0.162
Primary level (grade 0-7) 2 (50%) 2 (50%) 4
Secondary level (grade 8-12) 14 (87.5%) 2 (12.5%) 16
Unhealthy behaviour* during pregnancy (n=24) 1
Yes 9 (81.8%) 2 (18.2%) 11
No 10 (76.9%) 3 (23.1%) 13
Unhealthy behaviour *after pregnancy (n=23) 1
Yes 6 (85.7%) 1 (14.3%) 7
No 12 (75%) 4 (25%) 16
Partner drinking habits (n=20) 0.319
Yes 8 (88.9%) 1 (11.1%) 9
No 7 (63.6%) 4 (36.4%) 11
Previous SUDI (n=21) 1
Yes 3 (75%) 1 (25%) 4
No 13 (76.5%) 4 (23.5%) 17
Stillbirth (n=22) 1
Yes 7 (87.5%) 1 (12.5%) 8
No 11 (78.6%) 3 (21.4%) 14
*Unhealthy behaviour, alcohol/cigarette smoke/drug use; SUDI, sudden unexplained death in infancy
The same type of pathogen was detected in all three samples in nine of 28 positive cases (32%); of the 
nine cases, eight involved Metapneumovirus A/B and one involved K. pneumoniae. Similarly, 50% 
(14/28) cases had the same type of pathogen detected in two of three samples under study, including  
four cases infected with Metapneumovirus A/B, three with M. pneumoniae, two with K. pneumoniae,  
two with Streptococcus pneumoniae, one with P. jirovecii, one with Bocavirus and one with 
Staphylococcus aureus. 
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Figure 1. Cause of death (n= 30)






















Among the 28 SUDI cases with positive pathogen detection, seven (25%, 7/28) had a single type of 
pathogen detected. Table 4, summarized the distribution of a single pathogen detection from all the 
three samples. Co-infection by at least two respiratory pathogens under study was observed in 75% 
(21/28). Most of multiple pathogens co-detection was found in lung biopsy (Table 7). 
Metapneumovirus A/B was the most pathogen involved in pathogen co-detection accounting for 10% 
(1/10), 45% (5/11) and 71% (12/17) in cerebrospinal fluid, pericardial fluid and lung biopsy, 
respectively. The combination of pathogens detection in cerebrospinal fluid, pericardial fluid and lung 
biopsy are described in Tables 5, 6 and 7, respectively. 
Figure 3.Respiratory pathogens distribution in all the three samples
3.3.2 Microbiological data from routine laboratory investigation
Only two cases had blood culture data available, one of which had a positive detection of K. 
pneumoniae which was also confirmed by real-time PCR with positive detection in both the lung 
biopsy and pericardial fluid. The other, had S. aureus but this was not confirmed by PCR results.




















Table 4. Frequency of single detected respiratory pathogens from post-mortem samples
Respiratory pathogen Cerebrospinal fluid Pericardial fluid Lung biopsy
Virus
Human Metapneumovirus A/B 9 6 5 
Parainfluenza 1 ‒ 1 ‒
Bacteria
Klebsiella pneumoniae 1 1 ‒
Mycoplasma pneumoniae 2 3 ‒
Staphylococcus aureus 1 1 ‒
Fungi
Pneumocystis jirovecii ‒ ‒ 3 
Total 13 10 8
‒, not found
Table 5. Distribution of respiratory pathogens co-detections in cerebrospinal fluid 
Hcor229E HcorNL63 EV/PV HMPVAB Morax
Hcor229E





HMPVAB 0 0 1 ─
Morax 1 1 0 0
Hcor 229, Human coronavirus 229E HcorNL63, Human coronavirus NL63 EV, Enterovirus PV, 
Parechovirus HMPVAB, Human Metapneumovirus A and B Morax, Moraxella catarrhalis ‒, not 
found
Table 6. Distribution of respiratory pathogens co-detections in pericardial fluid 
HboV EV/PV FluC HMPVAB Kpneu Spneu Saur PCP
HboV ─ ─ ─ ─ ─ ─ ─
EV/PV 0 ─ ─ ─ ─ ─ ─
FluC 0 0 ─ ─ ─ ─ ─
HMPVAB 0 1 0 ─ ─ ─ ─
Kpneu 0 0 0 1 ─ ─ ─
Spneu 0 0 0 1 1 ─ ─
Saur 1 0 0 0 0 0 ─
PCP 0 0 0 2 0 0 0
Hbov, Human bocavirus EV, Enterovirus PV, Parechovirus FluC Influenza virus C HMPVAB, 
Human Metapneumovirus A and B Kpneu, Klebsiella pneumoniae Spneu, Streptococcus pneumoniae
Saur, Staphylococcus aureus PCP, Pneumocystis jirovecii ‒, not found
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Table 7 Distribution of respiratory pathogens co-detections in lung biopsy
HboV HMPVAB Para1 Haeinf Kpneu Legio Morax Mpneu Spneu Saur PCP
HboV ─
─ ─ ─ ─ ─ ─ ─ ─ ─
HMPVAB 0
─ ─ ─ ─ ─ ─ ─ ─ ─
Para1 0 0
─ ─ ─ ─ ─ ─ ─ ─
Haeinf 0 1 0
─ ─ ─ ─ ─ ─ ─
Kpneu 1 9 0 2
─ ─ ─ ─ ─ ─
Legio 0 3 0 0 2
─ ─ ─ ─ ─
Morax 1 2 0 2 6 0
─ ─ ─ ─
Mpneu 0 1 0 2 2 0 2
─ ─ ─
Spneu 0 4 1 2 6 0 3 2
─ ─
Saur 1 4 1 0 4 2 2 0 2 ─
PCP 0 8 0 1 8 1 2 1 4 3
Hbov, Human bocavirus HMPVAB, Human Metapneumovirus A and B  Para 1, Parainfluenza virus 1  
Haeinf, Haemophilus influenzae Kpneu, Klebsiella pneumoniae Legio, Legionella species Morax, 
Moraxella catarrhalis Mpneu Mycoplasma pneumoniae Spneu, Streptococcus pneumoniae Saur, 
Staphylococcus aureus PCP, Pneumocystis jirovecii ‒, not found
3.4 Correlation between pathological and microbiological investigation
The detection of significant pathological signs of infection in the lungs using Lodox® scanners 
correlate with positive detection of a potential pathogen in the lung biopsy (kappa= 0.73). Human 
Metapneumovirus A/B detection in the lung biopsy correlate with lower respiratory tract pathology 
findings on full body imaging using Lodox® scanners (kappa= 0.96). Among the six cases of 
unexplained SUDI, only two cases have Lodox® scanners results available. One shows bilateral 
pulmonary patchy infiltrate and the other does not show any abnormality. However four out of the six 
unexplained SUDI (67%, 4/6) had a positive PCR pathogen detection in at least one of the collected 
samples.
4. Discussion
A considerable number of SUDI mortalities are caused by respiratory tract infections 8, 22, 23, which are 
considered as one of the most frequent causes of death in children under one year of age worldwide 24. 
However, the association between respiratory infections and SUDI have been less well studied. The 
detection of specific respiratory pathogens in cases of SUDI provides data relevant to the 
development of prevention strategies. The aim of this study was to estimate the incidence of 
respiratory pathogens in SUDI cases in Cape Town (Western Cape, South Africa).  This is the first 
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study to investigate a large panel of respiratory pathogens in SUDI cases, including 21 viruses, 11 
bacteria, and one fungus. It also includes recommended samples for post-mortem microbiology such 
as pericardial fluid that have been recently identified as less affected by post-mortem bacterial 
translocation 25. Cerebrospinal fluid is considered as the most sterile post-mortem sample 26 and lung 
biopsy for being at the focal point of respiratory infection 27. Hence, detection of a potential pathogen 
from these samples under study should be considered as potentially causing or contributing to a cause 
of death.  
Human Metapneumovirus is an important cause of respiratory tract infections in previously healthy 
infants during the first year of life 28, 29. In the present study, the Human Metapneumovirus was the 
most predominant detected pathogen, accounting for more than half (57%, 17/30) of all cases. Eight 
of nine cases (89%) that had the same type of pathogen detected in all the three samples involved 
Human Metapneumovirus. Also, it was involved in 10% (1/10), 45% (5/11) and 71% (12/17) of 
respiratory pathogen co-detections in cerebrospinal fluid, pericardial fluid and lung biopsy,
respectively. Prior to this study, Human Metapneumovirus has never been reported in SUDI cases. 
This might be due to the fact that majority of studies include a limited number of pathogens. 
Therefore, the role of Human Metapneumovirus as a pathogen or co-pathogen in the occurrence of 
SUDI requires further investigation.
In contrast to the high incidence rate of AdV 23, 30, CMV 22 and Respiratory  syncytial virus RSV 10, 23, 
31 in SUDI cases worldwide, the present study did not find any case with the above mentioned  
viruses. A previous virological surveillance of SUDI cases conducted in the same area as the present 
study showed concordant results, with unexpected low detection rate of  both RSV and AdV 8. 
However, the peak incidence of RSV and AdV is observed during winter period 19, which was not 
included in the present study period. In addition, the absence of AdV, CMV and RSV might imply 
that the spectrum of respiratory pathogens involved in SUDI cases may be different across regions.  
S. aureus and S. pneumoniae have been implicated in SUDI deaths 10, 23, 26, 32, 33. In this study, both S. 
aureus and S. pneumoniae are detected mainly in lung biopsy samples (7/30, 23%). Similarly, 
previous studies have isolated S. aureus and S. pneumoniae from the same sample site using culture 
based techniques 26, suggesting a high implication of both bacteria in fatal lower respiratory tract 
infections. K. pneumoniae was the most frequently detected bacteria in lung biopsy (47%, 14/30). K.  
pneumoniae has been previously isolated from SUDI cases 32. Yet, both K. pneumoniae and M. 
catarrhalis have been given less consideration in SUDI investigation. An alternative possible 
explanation of the high incidence rate of K. pneumoniae in lung biopsy is the increased susceptibility 
to contamination in lung biopsy 27, 32, 34, which renders the interpretation of post-mortem 
microbiological results from lung samples more challenging 35. Also, the specificity of khe assay used 
to detect K. pneumoniae in the FTD® respiratory pathogens 33 Kit was found to detect some species 
of Klebsiella other than K. pneumoniae 44.
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Haemophilus influenzae has been frequently isolated from lung biopsy and cerebrospinal fluid 
samples in SUDI cases 10, 26, 32. However, the significant success of the pneumococcal conjugate 
vaccine might have reduced the incidence rate of H. influenzae infection 36. Hence the low detection 
rate of H. influenzae (2/30, 7%) in lung biopsy, and the absence of H. influenzae type B in the present 
study could be due to the fact that most of the study participants (83%, 25/30) had up to date 
immunization records. This high rate of immunization in the study participants would also explain the 
absence of Bordetella pertussis. 
A high incidence rate of P. jirovecii (50%, 15/30) was observed in lung biopsies and most of P.
jirovecii positive SUDI cases (37%, 11/30) involved multiple pathogen detection. As P. jirovecii is 
also found in healthy infants 37, the detection of P. jirovecii should be considered as a co-morbidity 
factor rather than the cause of death. Similarly, detected pathogens from lung biopsy should be 
regarded as contributing to death. However, pathogens that were detected from both cerebrospinal and 
pericardial fluid should be considered as potential cause of death. Recent studies have shown that 
respiratory infections in infants less than one year of age are a result of multiple pathogen colonisation 
38, 39. In this study, 73% showed multiple pathogen colonisations. Hence, SUDI deaths might be due to 
synergetic interaction between multiple pathogens colonisation in the respiratory system. 
The use of Lodox® scanners in the investigation of SUDI provided an effective, rapid diagnosis of 
lung pathology in SUDI cases. This agrees with previous studies in which pulmonary pathology are 
commonly observed on the radiology of SUDI cases 7, 40. The detection of significant pathological 
signs of infection in the lungs correlate with positive detection of a potential pathogen in the lung 
biopsy (kappa= 0.73), indicating the ability of the Lodox® Statscan® full-body imaging system to 
detect pathology on soft tissue. However, to determine the aetiology of the infection, further 
microbiological investigation is required. 
In six cases that remained unexplained after routine post-mortem examination, respiratory pathogens 
were detected in four (67%), suggesting an infectious cause of death rather than unexplained. This 
suggests that some SUDI cases are miscategorised as unexplained and results from post-mortem
microbiology could provide a possible cause of death. 
The most common characteristics of SUDI cases were in line with the literature. The male infants 
were predominant (67%, 20/30), which was also evidenced in several previous studies 8, 41. Improper 
sleeping conditions were a common observed characteristic in our study population, which also agrees 
with previous studies 8, 42, 43. Only the mother’s marital status was statistically significant with 
unexplained SUDI deaths; however, this may be due to the limited sample size.
This study has several limitations. The present study follows the routine investigation of SUDI cases 
at Salt River Forensic Pathology Laboratory (Cape Town, South Africa). Data related to toxicology 
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and histopathology were not available. The mentioned investigations are only investigated in the 
absence of pathological sign of infection after full-body imaging and post-mortem examination. The 
cell culture technique, considered as the ultimate diagnostic technique for infections in post-mortem 
settings. Only two cases had blood culture results available. One was confirmed by PCR results;
however, the other one with a positive S. aureus did not match with microbiological PCR 
investigation results.  A possible explanation to this finding is that S. aureus is part of the normal skin 
microbial community; therefore, it can be a result of contamination during sample collection or 
processing. 
5. Conclusion
This study provides the incidence of the most frequent respiratory pathogens involved in SUDI in the 
Cape Town metropolitan, Western Cape, South Africa.  The high rate of multiple pathogen detection 
in otherwise normally sterile site implicates respiratory co-infections in the pathology of SUDI. In 
addition, this study demonstrates the relevance of post-mortem microbiology as it provided an 
explanation of death in 67% of otherwise unexplained SUDI cases. The use of large panels of 
pathogens should be considered in the aetiological investigation of respiratory infection in SUDI. 
Further research should be considered to determine the seasonal respiratory pathogen distribution in 
cases of SUDI. 
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The aim of this research project was to study the incidence of respiratory pathogens in SUDI and 
analyse the correlation between findings from different techniques used in medico-legal investigation 
of SUDI cases in Cape Town, South Africa. 
The aim of the research was achieved by screening all cases of SUDI admitted at Salt River Forensic 
Pathology Laboratory (Cape Town, South Africa) during the period from February through May 
2015. The investigative techniques performed were post-mortem examination, full-body radiology 
and microbiological investigation. The study period mentioned in the research protocol was postponed 
due to the delay in obtaining the ethics approval from the Human Research Ethics Committee at the 
University of Cape Town, South Africa. The lack of control samples rendered the case control 
sampling approach proposed not achievable. 
The sampling procedure for lung biopsy was modified from the intended percutaneous needle lung 
biopsy to the lung biopsy after opening the body. The percutaneous needle lung biopsy sampling 
procedure, though it was previously found to be efficient for post-mortem bacteriological examination 
1,2 was not able to provide the required sample size (25mg of lung tissue ) for the automated nucleic 
acids extraction intended in this study. Cerebrospinal fluid was collected via sub-occipital puncture 
instead of lumbar puncture before opening the body. This minor change in cerebrospinal fluid 
collection was made after sub-occipital puncture was found to be more efficient as standard post-
mortem investigation recommend the use of either sub-occipital puncture or lumbar puncture to 
collect post-mortem cerebrospinal fluid for microbiological examination 3. Furthermore, sub-occipital 
puncture was used to collect cerebrospinal fluid in post-mortem virological investigation in Bali 4.
Due to the budget constraints, we did not screen blood samples collected in this study.
The routine microbiological investigation by the National Health Laboratory Service was not 
performed for all the cases included in the present study. According to the protocol, autopsy and 
subsequent histopathological and microbiological investigation were performed at Salt River Forensic 
Pathology Laboratory only in the absence of relevant pathological signs in keeping with natural 
causes of death after review of the clinical history, external body examination and full-body 
radiology. Therefore, only two cases (7%, 2/30) had their routine microbiological investigation by 
National Health Laboratory Service results available. This explains the lack of histopathology 
findings as was previously intended in the research protocol. These guidelines of SUDI investigation 
currently followed at the Salt River Pathology Laboratory could lead to missing potential infections 
and therefore to miss-categorisation of SUDI cases. According to Kennedy’s protocol, an 
international protocol for sudden unexpected child death investigation, a SUDI case undergoes
extensive medico-legal investigation including: full body autopsy, histopathology, toxicology, 
biochemistry, bacteriology and virology examination before it is categorised 5.
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The main findings of this study were the high rate of respiratory pathogens (including multiple 
pathogens) detection in otherwise normally sterile body sites (cerebrospinal fluid and pericardial 
fluid) in SUDI cases. Pericardial fluid is the most recommended sample type in the diagnosis of post-
mortem infection 6. Human Metapneumovirus A/B was the most common pathogen detected. 
Moreover, the present study is the first to report Human Metapneumovirus A/B in SUDI cases, and its 
high implication in SUDI cases warrants further investigation. 
In this study, the transitioning from Lodox® Statscan® to Lodox® Xmplar-dr® did not allowed 
performing the full body radiological imaging for all the SUDI cases. Nevertheless, using Lodox®
scan, lung pathology suggestive to lower respiratory infections was found in two-third (12/18) of 
explained SUDI cases in our study. Of note, the accuracy of post-mortem imaging using Lodox® scan 
was not in the scope of this study. Therefore, studies investigating the value of Lodox® scan in the 
diagnostic of respiratory infection are needed.
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This pilot study provided a baseline for post-mortem microbiological analysis of SUDI cases in our 
study setting. Although the samples analysed in the present study provided relevant information on 
the contribution of respiratory pathogens in SUDI cases, a larger sampling strategy with various 
diagnostic techniques would have eliminated biases associated with limited sample size and therefore 
add value to the present knowledge. A control group of healthy infants would determine the accuracy
of post-mortem imaging in the diagnosis of infections. The use of other recommended samples for 
post-mortem diagnosis of infections such as heart blood and liver biopsy should also be considered. 
Furthermore, the present study investigated SUDI cases during a specific period of the year (February 
to May) and therefore, a study investigating the dynamics of respiratory pathogens involved in SUDI 
cases over a year period should be envisaged.
The lack of standard procedures in the investigation of respiratory pathogens in cases of SUDI that 
have been outlined in the research protocol (Part 2) of this dissertation highlighted the need to 
establish a general protocol at national level. The major respiratory pathogens found in cases of SUDI 
as detailed in Part 4 (a ready to publish article) of this dissertation provide an initial step in the 
identification of respiratory pathogens that should be included in the standard procedures. However, if 
a control group is used, it would facilitate the interpretation of microbiological results.
